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CHAPTER 1 INTRODUCTION 
1.1 Summary 
                The long term goal of my thesis research is to understand how tissue-specific 
phosphorylations on the small mitochondrial protein, cytochrome c (Cytc), regulate its 
functions, under both physiologically healthy and stressed conditions, and to identify the 
cell signaling pathways targeting Cytc. Cytc is a functionally diverse protein that carries 
electrons in the electron transport chain and plays a critical role in cellular apoptosis, two 
diverse pathways that maintain cellular health that are active under diverse conditions. 
Since Cytc plays a pivotal role in both these highly divergent pathways, regulation of the 
protein is very important—phosphorylation of the protein under physiological conditions 
hence implies a regulation by cell signaling pathways that have yet to be identified and 
studied. Previous work by our lab suggests the importance of reversible phosphorylation 
of Cytc in regulating its functions 1-4. We hypothesize that under healthy conditions, 
phosphorylated Cytc partially inhibits mitochondrial respiration and maintains healthy 
mitochondrial membrane potential, preventing ROS generation, while cellular stress-
mediated dephosphorylation leads to increased respiration and ROS generation, initiating 
apoptosis. To further test this hypothesis and to extend our understanding of Cytc 
phosphorylation on its functions, I conducted two studies. In the first study, I investigated 
the physiological phosphorylation status of Cytc in mammalian kidney tissues. To begin 
with, I purified bovine kidney Cytc in the presence of phosphatase inhibitors, identified 
threonine phosphorylation by immunoblot analysis, and determined threonine 28 
phosphorylation by immobilized metal affinity chromatography/nano-liquid 
chromatography/electrospray ionization mass spectrometry (Nano/LC/ESI/MS/MS). To 
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characterize the effect of Thr28 phosphorylation on Cytc functions, I mutated Thr28 to 
glutamate, a phosphomimetic mutation, and alanine, a nonphosphorylatable control. I 
went on to express and purify wild-type, the phosphomimetic mutant and the non-
phosphorylatable mutant Cytc in bacterial cells. I also expressed and analyzed wild-type, 
the phosphomimetic mutant and the nonphosphorylatable mutant Cytc in mammalian 
cells to determine the effects of the Cytc mutations on the functions of the protein in vitro 
and on overall cellular metabolism and physiology, under healthy and stressed conditions. 
I also found that Thr28 phosphorylation is AMP kinase-mediated, and AMP kinase 
colocalizes with Cytc to the mitochondrial intermembrane space. Our data suggest that 
Thr28, conserved in mammalian Cytc, is an important regulatory site that leads to 
regulation of ETC flux via ‘controlled respiration,’ preventing m hyperpolarization, a 
known cause of ROS and trigger of apoptosis (discussed in Chapter 2, manuscript under 
preparation). In the second study, the phosphorylation status of Cytc in ischemic brain 
was investigated to determine if insulin-induced neuroprotection and inhibition of Cytc 
release in ischemic brain was associated with Cytc phosphorylation. We used an animal 
model of global brain ischemia, and found a 50% decreased death rate of CA1 
hippocampal neurons after neuroprotective post-ischemic insulin administration as 
compared to untreated controls. The increased survival of CA1 neurons was correlated 
to inhibition of Cytc release from mitochondria into cytosol 24 hours post reperfusion, 
which in turn was mediated by Cytc phosphorylation on Tyr97. We thus propose that Cytc 
is phosphorylated by an insulin-dependent signaling pathway, and this may impede with 
its release from mitochondria and its ability to induce apoptosis (discussed in Chapter 3, 
manuscript published in PLoS One, 2013 8(11):e78627). 
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1.2 Cytochrome c  
                Cytc is a small, 12.4 kDa globular protein localized in the mitochondrial 
intermembrane space under healthy or unstressed condition. It is a hemoprotein, with the 
heme group covalently linked to cysteines 14 and 17 of the peptide chain via thio-ether 
bonds. The hexa-coordinated, low-spin iron in the heme group is coordinated by His18 
and Met80 residues. The human Cytc protein is encoded by the nuclear gene, CYCS. [1][2] 
Being a nuclear-encoded gene, Cytc is translated in the cytoplasm as apo-cytochrome c. 
The heme group is attached to apo-cytochrome c upon its translocation to the 
mitochondria. Under normal (i.e., non-apoptotic) conditions Cytc is located in the 
intermembrane space of mitochondria, and is mostly associated with the outer surface of 
the inner mitochondrial membrane by electrostatic and hydrophobic interactions with the 
negatively charged phospholipids, in particular cardiolipin5.  
                Cytc is classified to the family of proteins containing covalently linked c-type 
cytochromes. Unlike other cytochromes, it is a positively charged, highly water-soluble 
protein, with a solubility approximately 100 g/L6. It is highly conserved across all species, 
with its presence in plants, animals, and several unicellular organisms. With only a few 
residues varying in mammals, it contains a highly conserved amino acid sequence. The 
high level of conservation makes it an extensively studied protein over the years, 
providing an insight into evolutionary biology. Studies of cytochrome c sequences 
revealed that sequences from humans and chimpanzees, our closest relative, were 
identical, whereas it was different from horses by 10 residues7. 
                Cytochrome c is an essential protein in the electron transport chain between 
the quinol:cytochrome c oxidoreductase (complex III, or cytochrome bc1) and the 
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cytochrome c oxidase (complex IV, CcO or cytochrome a/a3), where it is involved in the 
generation of energy in the form of ATP. It is also one of the major players in intrinsic 
mitochondrial apoptosis. Cytc can undergo oxidation and reduction, but it does not bind 
oxygen. This feature is utilized in the oxidative phosphorylation process, where Cytc 
accepts a single electron from coenzyme Q – cytochrome c reductase and donates it to 
cytochrome c oxidase, the final electron acceptor that converts molecular oxygen to 
water. The latter is the proposed rate limiting step of the ETC7. While its function as an 
electron carrier is revealed under healthy cellular conditions, under stressed conditions, 
cytochrome c unveils its role in the intrinsic mitochondrial apoptosis cascade, by being 
released from the mitochondrial intermembrane space into the cytosol.  
1.3 History of Cytochrome c 
                Microspectroscopic studies by C. S. McMunn (1852-1911) on tissue specimens 
across various phylum, from coelenterates to man, lead to the origination of the idea that 
heme proteins play a role in respiration. McMunn carefully removed blood from each 
sample and found a pigment that displayed a common absorption spectrum, thereby 
discovering cytochrome c in 1884. He termed the pigment myohaematin (in muscles) and 
histohaematin (in other tissues). He demonstrated intensification of bands by reduction 
and weakening by oxidation. Thus, he discovered a protein capable of redox functions in 
vertebrates and invertebrate, and showed that the chemistry of energy production in the 
body took place deep in the cellular structure of the tissues, and not just in the blood as 
had been previously assumed. These respiratory pigments are now known as 
cytochromes, and are fundamental to energy metabolism.  
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                David Keilin, a Polish parasitologist in Cambridge, rediscovered cytochromes 
in 1925, and recognised MacMunn’s achievement by identifying their function in cellular 
respiration 8. Keilin’s studies identified the same absorption bands identified by MacMunn 
not only in the fly, but in Bacillus subtilis and in baker’s yeast. Keilin christened the 
ubiquitous colored pigments cytochromes. Cytochromes were further classified by Keilin 
by their lowest energy absorption band under reducing condition, naming them 
cytochrome a (604nm), b (564nm) and c (550nm)8. Keilin laid out the basic picture of the 
respiratory chain in the 1920’s. Due to the presence of an iron (Fe) atom in heme it was 
believed that cytochrome c could act as an electron carrier by undergoing oxidation 
reduction reactions. 
1.4 Structure of cytochrome c 
                Horse heart Cytc was one of the first proteins to be crystallized. The c-type 
cytochromes, among the best studied players in mitochondrial electron transport, contain 
redox-active heme proteins for which X-ray crystallographic structures of Cytc revealed 
that the heme group is covalently linked to the mature peptide chain of the protein (note 
that the mature protein lacks the N-terminal methionine residue) by two thioether bonds 
between the heme vinyls and cysteine residues 14 and 17 of the conserved heme-binding 
motif on the protein9,10. The heme iron exists in a hexacoordinate configuration with the 
His18 and Met80 residues acting as ligands. The heme iron-Met80 bond results in a weak 
695 nm absorption band in the spectrum of oxidized Cytc, the lack of which indicates that 
the protein is not correctly folded (Dickerson and Timkovich, 1975). Surrounded by 
aliphatic and aromatic side chains, the heme group resides in a very hydrophobic 
environment and this, together with the iron ligands His18 and Met80, provides an 
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explanation for the high redox potential of Cytc (~260 mV in mammals) 4. Only 7.5% of 
the heme surface remains exposed to the solvent 10, and it is this site that is used to 
transfer electrons from complex III to complex IV 11-14. 
1.5 Cytochrome c is an essential protein 
                Murine embryos that are lacking Cytc die in utero by midgestation15. They show 
a clearly evident and profound developmental delay at E8.5 and do not survive after stage 
E10.5. However, cell lines established from early Cytc null embryos are viable under 
conditions that compensate for defective oxidative phosphorylation, and they are resistant 
to apoptosis via stimuli such as UV irradiation, serum starvation and staurosporine15, and 
show reduced caspase-3 activity, but are highly sensitive to TNFα mediated cell-death 
signals16,17. This is because the intrinsic Cytc-dependent apoptotic pathway remains 
inactive, while the extrinsic apoptotic pathway remains active. Since the primary role of 
Cytc is to carry electrons in the ETC, Cytc null cells suffer from a defective electron 
transport and oxidative phosphorylation system, leading to early lethality of the embryos. 
1.6 Functions of cytochrome c: 
1.6.1 Role of cytochrome c in oxidative phosphorylation 
                Cytc is located in the mitochondrial intermembrane space, and in the terminal 
step of the ETC, reduced Cytc carries a single electron from complex III to complex IV 
(cytochrome c oxidase), which in turn oxidizes Cytc and reduces a single molecule of 
oxygen to water on transfer of four such electrons. Under physiological conditions in intact 
mitochondria, this is the rate-limiting step of the ETC 18-22. The irreversible conversion of 
oxygen to water is accompanied by a free energy change of ΔGo’= -100 kJ/mol 23.  
1.6.2 Cytochrome c and Erv1-Mia40-coupled protein import 
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                Cytc is synthesized from its nuclear gene as apocytochrome c, imported into 
mitochondrial intermembrane space and is converted into the holo-form by the Cytc heme 
lyase-catalyzed heme addition 24. In the intermembrane space, it functions in the redox-
coupled protein import pathway along with the transporters of outer membrane (TOMs), 
Erv1, and Mia40 proteins. Together, they import small transporters of inner membrane 
(TIMs) and other proteins that contain the twin CX3C and CX9C motifs into the 
intermembrane space 25. Then, these proteins undergo post-import modifications such as 
alternative folding, and on being oxidized by Mia40, these proteins form disulfide bonds 
between the cysteine residues that finally lock alter their tertiary structure 26. Mia40 is 
reactivated by Erv1-mediated oxidation, and Erv1 is reoxidized by Cytc 27. The electrons 
that are sequentially transported from the imported protein to Mia40 to Erv1 to Cytc finally 
feed into the ETC. 
1.6.3 Role of cytochrome c as both a ROS scavenger and producer 
                A) During the transfer of electrons by the ETC complexes, redox intermediates 
are generated mainly by complexes I and III and the reduced ubiquinol pool. These 
intermediates can also take part in various side reactions and as a result, transfer 
electrons directly to oxygen, generating ROS as a byproduct of the ETC 28,29. The cells 
are equipped with radical scavenging enzymes to neutralize ROS, such as superoxide 
dismutase (SOD) and catalase. Cytc is constantly reduced by complex III and oxidized 
by complex IV, and is thus capable of performing the functions of an antioxidant. Along 
with SODs and catalase, Cytc also removes unpaired electrons from superoxides 
generated in the intermembrane space, regenerating O2 30,31, finally donating these 
electrons to cytochrome c oxidase (COX). It also scavenges hydrogen peroxides 32.  
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                B) A splice variant of the growth factor adapter Shc, namely p66shc, is found 
throughout the cell with a subset localizing to the mitochondria, where it affects 
mitochondrial function 33. Under stress conditions, mitochondrial p66shc is oxidized by 
electrons supplied by Cytc, which leads to the p66shc-mediated production of hydrogen 
peroxide 34. The increase in ROS production via p66shc as part of the apoptotic pathway 
would provide Cytc with peroxide equivalents necessary for the oxidation of cardiolipin, a 
process that is required for its release from the mitochondria as discussed below. Indeed, 
release of Cytc correlates with the H2O2 production activity of p66shc 35, and could be a 
significant switch utilized by the cell as an initiating event of apoptosis. 
1.6.4 Role of cytochrome c in apoptosis 
                Cytc plays an essential function in the induction of apoptosis, as was 
established more than a decade ago 36, and it is not degraded during apoptosis 37. 
Thousands of studies have furthered this knowledge and now, the established model of 
mitochondrial type II apoptosis considers Cytc release from mitochondria into the cytosol 
and binding to apoptotic protease-activating factor 1 (Apaf-1) as a key committing steps 
38. The essentiality of Cytc for apoptosis is further strengthened by the fact that Cytc null 
cell lines show reduced caspase-3 activation after stimulation of apoptosis 15, along with 
a decreased rate of ATP production. Previous work also indicates that Cytc can be 
reversibly released and taken up by isolated mitochondria 39, and membrane rupture or 
mitochondrial permeability transition pore opening are not always necessary for the 
execution of apoptosis 40. However, before the point of no return is reached, a certain 
proportion of Cytc must be released from the mitochondria 41. 
1.6.5 Cytochrome c-catalyzed cardiolipin oxidation precedes cytochrome c release 
9 
 
                Cardiolipin is a mitochondria-specific lipid and mainly localized in the inner 
mitochondrial membrane where it binds ~15-20% of Cytc 42,43. During apoptosis, Cytc 
functions as a cardiolipin peroxidase 44, and this oxidation decreases the affinity of Cytc 
for cardiolipin 44,45, thereby increasing the amount of free Cytc in the intermembrane 
space, which can then be released into the cytosol once the mitochondrial outer 
membrane is ruptured. This peroxidase function of Cytc depends on the physical 
interaction between Cytc and cardiolipin and involves a tyrosine radical 44,46,47. 
1.7 Cytochrome c regulation: 
                Being at the crux of the ETC, the terminal rate-limiting step of the ETC is 
regulated by various means, as described hereunder. 
1.7.1 Allosteric regulation 
                Both Cytc and COX are regulated allosterically by the ATP/ADP ratio. ATP 
binds to Cytc and to COX, acting as an allosteric inhibitor 48-50. The structure and 
electrostatic properties of both the proteins are presumed to be changed upon ATP 
binding, which decreases the capability of Cytc to transfer electrons 51,52, thereby 
downregulating ETC flux when there is already a high level of ATP within the cell.  
1.7.2 Regulation via expression of tissue-specific isoforms 
                Another mode of regulation commonly seen in the ETC proteins is via tissue-
specific isoform expression. A testis-specific isoform of Cytc (T-Cytc) exists in germinal 
epithelial cells of rodents 53, having 86% homology with the amino acid sequence of 
somatic Cytc (S-Cytc), and is the predominant form of Cytc in mature sperm 53-55. T-Cytc 
shows three-fold higher H2O2 reduction rates and about four-fold higher apoptotic activity 
55. However, this isoform is not evolutionarily conserved, and exists as a pseudogene in 
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humans 7,56. Human Cytc, which is ubiquitously expressed including in testis, shows 91% 
homology to mouse Cytc-S and 82% homology to Cytc-T.  
1.7.3 Regulation by post-translational modifications 
                The third mode of Cytc regulation is by post-translational modifications. The 
overall working hypothesis in our lab is that in higher organisms, the main mode regulating 
energy production is through cell signaling pathways triggered by various extracellular 
cues. Cytc has been found to be trimethylated at evolutionarily conserved residue Lys77 
in S. cerevisiae and plants 57-60. Also established is the role of Lys72-methylation in 
determining the pro-apoptotic activity of Cytc 61. Lys77-trimethylation was suggested to 
be important for protection of Cytc from proteolytic cleavage, and abrogation of 
proapoptotic activity. In addition, Cytc nitrosylation on its heme iron during apoptosis has 
been suggested to increase the protein’s proapoptotic function 62.   
1.7.3.1 Regulation by reversible phosphorylations 
                Over 400 phosphorylation sites have been mapped on the oxidative 
phosphorylation complexes from various species to date 63, and  a few recent studies 
indicate that several kinases and phosphatases are present in the mitochondria or that 
they can translocate into the mitochondria after stimulation of signaling pathways as was 
shown for the EGF receptor 64. However, of the sites mapped, only a handful have been 
functionally studied (mainly by our group), while the kinases and phosphatase involved in 
these phosphorylations remain elusive for essentially all mapped sites. In mammals, 18 
phosphorylation sites have been mapped on COX and 4 on Cytc 65,66.  
                The recent discovery of in vivo tyrosine phosphorylation of mammalian Cytc by 
our lab has helped in our understanding of how kinases and phosphatases differentially 
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modify Cytc functions during different cellular conditions. Cytc was previously isolated by 
our lab in the presence of the nonspecific phosphatase inhibitors fluoride and vanadate 
to maintain phosphorylations, and has been found to be phosphorylated on two different 
highly conserved tyrosine residues by mass spectrometry, namely Tyr97 and Tyr48 in 
heart and liver tissues, respectively 1,67. This indicates that cell signaling pathways target 
the protein in a tissue-specific manner. As discussed above, oxidized Cytc exhibits a 
specific absorption band at 695 nm due to a bond between a Met80 residue and the heme 
iron, a signal called the “indicator of trouble”, which is lost when the protein is either 
denatured or dysfunctional (Dickerson and Timkovich, 1975). Tyr97-phosphorylated Cytc 
showed a shift in this band from 695 nm to 687 nm, suggesting an effect on the heme 
environment 1. Both phosphorylations also had a direct effect on the various functions of 
Cytc. For example, both tyrosine phosphorylations resulted in decreased, partially 
inhibited oxygen consumption in the reaction with isolated COX in vitro, with Tyr97-
phosphorylated Cytc showing sigmoidal kinetics, while Tyr48-phosphorylated Cytc 
showed hyperbolic kinetics, similar to alkaline phosphatase-treated unphosphorylated 
Cytc 1,67. Tyr48 phosphorylation has been studied in detail by creating a Tyr48Glu 
phospho-mimetic mutant, and was shown to completely abolish activation of caspase3 in 
vitro 68. This suggests that Tyr48-phosphorylation might be an important regulator of the 
protein’s function as an initiator of mitochondrial type II apoptosis. In the cellular context, 
this regulation might be occurring through a phosphorylation-mediated change in 
conformation of the native protein that changes the interaction between Cytc and Apaf1 
in the cytosol, and results in impaired apoptosome formation. Lys7 is one residue that is 
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important for this interaction 69, and being spatially located right next to Tyr97, might be 
regulated by phosphorylation of that site. 
                In addition to Cytc, COX subunits have also been found to be phosphorylated 
at various sites by different pathways, including protein kinase C signaling, receptor 
tyrosine kinase, and inflammatory signaling through the TNFα signaling pathway. It was 
seen that after in vitro dephosphorylation of cow liver COX, the inhibitory effect of ATP on 
COX was lost 70. This finding rationalizes studies of allosteric regulation of phosphorylated 
Cytc and COX by ATP. 
1.7.3.2 Regulation of Cytc by site-specific phosphorylations, in mammalian kidneys 
and brain under physiologically healthy and stressed conditions 
                To continue my research on extending our knowledge and understanding of 
how phosphorylation of Cytc affect its functions under healthy and stressed conditions, I 
chose to work with tissues that are physiologically different than heart and liver tissues. 
In Chapter 2, I show that mammalian kidney Cytc is phosphorylated at Thr28 under 
physiologically healthy conditions, a conserved site in mammalian Cytc. My results 
suggest that Thr28 is an important regulatory site, involved mainly in maintaining optimal 
intermediate mitochondrial membrne potential (m) levels, thereby regulating energy 
production and preventing ROS generation. Also, my results suggest that Thr28 
phosphorylation of kidney Cytc in the mitochondrial intermembrane space is mediated by 
AMPK, a metabolic sensor that was found to be basally active in kidney. In Chapter 3, we 
show that neuroprotective insulin treatment prior to brain ischemia/reperfusion results in 
phosphorylation of brain Cytc on Tyr97,  leading to decreased Cytc release from 
mitochondria into the cytosol, resulting in reduced death of neurons, and thus 
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neuroprotection. The data in Chapter 3 have been published 71. Chapter 4, contains 
conclusions and future directions. 
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CHAPTER 2 AMPK-MEDIATED PHOSPHORYLATION OF CYTOCHROME c 
THREONINE 28 REGULATES ELECTRON TRANSPORT CHAIN ACTIVITY IN 
KIDNEY 
2.1 Introduction 
                Cytochrome c (Cytc) is a small (12 kD) globular nuclear-encoded mitochondrial 
protein containing a covalently attached heme group. It functions in the electron transport 
chain (ETC) as a single electron carrier between bc1 complex (complex III) and 
cytochrome c oxidase (CcO, complex IV), and is thus essential for aerobic energy 
production. The second important role of Cytc is seen under conditions of stress, when it 
functions as a crucial pro-apoptotic signal 72. During apoptosis, Cytc is released from 
mitochondria into the cytosol, where it interacts with Apaf-1 to form the apoptosome, 
which in turn activates caspase-9 and the downstream executioner caspase cascade. 
Furthermore, Cytc functions as a cardiolipin peroxidase during the early phase of 
apoptosis, when it oxidizes the mitochondrial membrane lipid cardiolipin, thus facilitating 
its own release from the inner mitochondrial membrane. In contrast, under healthy, non-
apoptotic conditions Cytc acts as a scavenger of reactive oxygen species (ROS) 31, and 
it takes part in other redox reactions inside mitochondria including redox-coupled protein 
import 26 and reduction of p66Shc, a protein that is implicated in the generation of ROS, 
apoptosis, and in regulating lifespan 34. Given the multiple functions of Cytc it is not 
surprising that it is tightly regulated. Two regulatory mechanisms via expression of a 
somatic and testis-specific isoform pair and allosteric regulation through binding of ATP 
have been known for over 30 years 49,53. A third mechanism via reversible 
phosphorylation was discovered recently when we purified bovine Cytc from heart and 
liver tissue under conditions preserving the physiological phosphorylation status. The two 
proteins were phosphorylated respectively on Tyr97 and Tyr48 73,74. Both modifications 
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lead to a partial inhibition of respiration. In addition, the phosphomimetic Tyr48Glu 
substitution abolished the capability of Cytc to trigger apoptosis, suggesting that Cytc 
phosphorylation regulates apoptosis at the level of the apoptosome 75. Here we report 
that Cytc purified from bovine and rat kidney tissues in the presence of phosphatase 
inhibitors is phosphorylated on threonine 28 (Thr28). In vivo phosphorylated and 
Thr28Glu phosphomimetic Cytc lead to an inhibition of respiration in the reaction with 
CcO. Introduction of wild-type (WT) and Thr28Glu phosphomimetic Cytc into Cytc 
knockout cells shows that intact cell respiration, mitochondrial membrane potential (m), 
and ROS levels are reduced. This suggests that Cytc phosphorylation can regulate ETC 
flux, preventing m hyperpolarization, a known trigger of ROS production and apoptosis 
76. Finally, we provide in vivo and in vitro evidence suggesting that phosphorylation of 
Thr28 is mediated by AMP kinase (AMPK), which co-localizes with Cytc in the 
mitochondrial intermembrane space. This is the first report of a mapped phosphorylation 
site on a mammalian oxidative phosphorylation component, together with functional and 
structural analyses and a kinase candidate mediating this site-specific modification. 
2.2 Materials and methods 
2.2.1 Isolation of cytochrome c from bovine kidney tissue 
                Reagents and chemicals were purchased from Sigma unless stated otherwise. 
All procedures involving animal tissues were approved by the Wayne State University 
Institutional Animal Care and Use Committee. Kidneys from freshly slaughtered cows 
were snap frozen on dry ice, and stored at -80ºC until used for Cytc purification by the 
acid-extraction method 74. For a detailed protocol see Supplemental Information. 
2.2.2 Western analyses 
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                Western analyses were performed using the enhanced chemiluminescence 
method. See Supplemental Information for antibody details. 
2.2.3 Mass spectrometry of purified cytochrome c to detect site-specific 
phosphorylation 
                Phosphorylation sites mapping on purified kidney Cytc was performed after 
tryptic digestion and TiO2 enrichment of phospho-peptides, following C18 reversed-phase 
chromatography as described 71. Peptides were injected into the mass spectrometer (LTQ 
Orbitrap-Velos, Thermo Scientific, Waltham, MA) after electrospray ionization. MS/MS 
spectra were obtained in positive ion mode, assigned to peptide sequences from the 
UniProt protein database, searched with the MASCOT algorithm for PTMs, and manually 
verified. 
2.2.4 Mutagenesis, expression, and purification of cytochrome c variants 
                Rodent somatic Cytc cDNA was cloned into the pLW01 expression vector as 
described 75 and threonine 28 (Thr28) was mutated to the phosphomimetic glutamate and 
nonphosphorylatable alanine as an additional control by mutagenesis PCR. Constructs 
were transformed into competent E. coli C41 (DE3) cells for protein overexpression 75. 
Cells were lysed using a French Pressure Cell Press and Cytc variants were purified by 
ion exchange chromatography as described above for kidney Cytc isolation. A similar 
mutagenesis was used for expression of Cytc variants in Cytc double knockout mouse 
lung fibroblasts using the pBABE-puro expression plasmid (Addgene, Cambridge, MA) 
following selection of stably expressing cell lines. Wild-type and Cytc double knockout 
lung fibroblasts were previously characterized in detail 77. See Supplemental Information 
for details. 
2.2.5 Crystal structure determination 
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                Briefly, using the PHENIX suite of programs 78, the structure of WT Cytc was 
solved by molecular replacement using chain-A of human Y46F Cytc 79, refit automatically 
to the experimental electron density with PHENIX, and refined to obtain occupancy values 
for the FC6 ligands. The refinement was completed to an R-free of 0.159 at 1.12 Å 
resolution using REFMAC5 80 with parameters optimized by PDB_REDO 81. The WT 
structure (5C0Z.pdb) was then used to solve, refit, and refine the structures of the 
Thr28Ala (5C9M.pdb) and Thr28Glu (5DF5.pdb) mutants at 1.36 Å (Rfree: 0.170) and 
1.30 Å (Rfree: 0.178) resolution, respectively. All proteins were oxidized with 5 mM 
K3Fe(CN)6 prior to crystallization. Full details and comparative statistics are provided in 
Supplemental Table 1. 
2.2.6 Cytochrome c oxidase (CcO) activity measurements 
                CcO activity with Cytc variants was determined using the polarographic method 
as described 82. For a detailed protocol, see Supplemental Information.  
2.2.7 Caspase 3 activation by cytochrome c variants 
                The capability of Cytc purified from bovine kidneys and the bacterially 
expressed Cytc mutants to induce downstream caspase 3 activity were assessed in vitro 
with cytoplasmic extracts of a mouse lung fibroblast cell line lacking both the somatic and 
testis-specific Cytc genes 77 as described 75. For a detailed protocol see Supplemental 
Information.  
2.2.8 Measurement of Cytc redox potential, heme degradation, and oxidation and 
reduction rates 
                The midpoint redox potential (E0’) was analyzed spectrophotometrically as 
described 75. The kinetics of oxidation of 15 µM ferro-Cytc with 100 µM H2O2 and reduction 
18 
 
of 15 µM ferri-Cytc with 200 µM ascorbate was measured spectrophotometrically at 550 
nm, and heme degradation in the presence of 3 mM H2O2 was determined via dissipation 
of the 408 nm Soret band as described 55. For detailed protocols see Supplemental 
Information. 
2.2.9 Peroxidase activity of Cytc mutants 
                Assessment of peroxidase activity 75 with Amplex Red reagent was performed 
by measuring the fluorescence of resorufin, an oxidation product of Amplex Red. Cytc (1 
μM) was incubated with liposomes containing TOCL/DOPC in ratio 1:1 for 10 min. 
Peroxidase reaction was started by addition of Amplex Red (50 μM) and H2O2 (50 μM) 
and was carried out for 20 min during which the reaction rate was linear. Fluorescence 
was detected by employing a “Fusion R” universal microplate analyzer by using an 
excitation wavelength of 535 nm and an emission wavelength of 585 nm. 
2.2.10 In vitro phosphorylation of cytochrome c with AMP kinase 
                Cow heart Cytc (300 pmoles; Sigma) was incubated with 3 pmoles of AMPK 
(AMPK 1/1/1, Active SignalChem, P47-10H) at 37ºC for 5 or 30 min in the presence 
and absence of AMP (125 M) in 25 mM MOPS (pH 7.2), 12.5 mM beta 
glycerophosphate, 25 mM MgCl2, 2 mM EDTA, 0.25 mM DTT, and 1 mM ATP. Samples 
were analyzed by Western blot and mass spectrometry. 
2.2.11 Immunoprecipitation and Western analyses from tissue homogenates 
                All Western analyses from tissue homogenates were done using 20 µg of whole 
tissue homogenates. All immunoprecipitations from tissue homogenates were done with 
1 mg of tissue homogenate. For immunoprecipitations, 50 µL of bead (ImmunoCruz 
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IP/WB Optima E and F Systems: sc-45042 and sc-45043) and 5 µg antibody were allowed 
to conjugate overnight at 4ºC, centrifuged (22,000 x g) for 30 seconds and washed twice 
with 500 µL PBS. Immunoprecipitation was performed by addition of 1 mg tissue 
homogenate and rotation overnight at 4ºC. 
2.2.12 Tissue Treatments with AMPK activator A-769662 and inhibitor Compound 
C  
                Fresh mouse kidneys were minced and treated with 500 µM A769662 (AMPK 
activator, Tocris, #3336) or 3 µM Compound C (AMPK inhibitor, Sigma, P5499) for 1 h 
following Western analysis of the soluble fraction. In addition, AMPK was 
immunoprecipitated from kidney homogenates after treatment with 500 µM A769662 for 
1 h to analyze Cytc co-immunoprecipitation. See Supplemental Information for details. 
2.2.13 Measurement of mitochondrial oxygen consumption rate tissue 
homogenates 
                Respiration of intact mitochondria in tissue homogenates was determined as 
described 83. For a detailed protocol see Supplemental Information. 
2.2.14 Presence of AMP kinase in mitochondria and mitochondrial subfractionation 
                Mouse kidneys were freshly harvested and washed in ice-cold isolation buffer 
(10 mM Tris, 1 mM of EGTA/Tris, 200 mM sucrose, pH 7.4 adjusted with MOPS) 84, 
minced, and homogenized with 20 strokes using a dounce homogenizer on ice following 
mitochondria isolation by sucrose density gradient purification. The mitochondrial pellet 
was subfractionated into an intermembrane space fraction and a mitoplast and outer 
membrane fraction. For detailed protocols see Supplemental Information. 
2.2.15 Measurement of oxygen consumption rate in intact cells 
                Per well, 70,000 cells were cultured in growth media (DMEM, supplemented 
with 10% FBS, 2% penicillin/streptomycin, 1 mM pyruvate and 50 µg/mL uridine) using 
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Seahorse XFe24 plates. After overnight culture, growth media was replaced with XF 
media, pH 7.4, and intact cell respiration was measured. 
2.2.16 Mitochondrial ROS measurement 
                Cells expressing Cytc variants were cultured in 12 well plates and incubated 
with 5 µM Mitosox for 30 min in at 37ºC. Cells were washed with PBS and fluorescence 
analyzed with a Synergy H1 plate reader (BioTek, Winooski, VT) by using excitation and 
emission wavelengths of 510 nm and 590 nm. 
2.2.17 ATP, mitochondrial membrane potential, and cell viability measurements  
                ATP levels were measured from lung fibroblast cells expressing Cytc variants 
applying the bioluminescent method. Mitochondrial membrane potential (ΔΨm) and cell 
viability were measured with JC-1 (Molecular Probes) and tryphan blue staining, 
respectively. For detailed protocols see Supplemental Information. 
2.2.18 Isolation of cytochrome c from bovine kidney tissue 
                All steps were performed at 4ºC or on ice. Kidney tissues were homogenized 
in 100 mM phosphate buffer, pH 4.5, adjusted with acetic acid, and incubated overnight 
at 4ºC. Under those conditions most cellular proteins denature and precipitate, whereas 
Cytc is extracted and stays in solution. The homogenate was centrifuged at 15,810 x g 
for 35 min, supernatants decanted through cheesecloth, and pH adjusted to 7.4 with KOH, 
while simultaneously adding protease (10 mM PMSF) and phosphatase inhibitors (1 mM 
KF, 1 mM Na-orthovanadate), thus preserving the phosphorylation state of Cytc. The 
supernatant was incubated at 4ºC for 20 min and centrifuged following ion exchange 
chromatography. First, the supernatant was passed through a DE52 anion exchange 
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column equilibrated with 20 mM phosphate buffer, pH 7.4, 3.6 mS/cm conductance. Cytc 
was collected in the flow through, which was pH readjusted to 6.5 and applied to a CM52 
cation exchange column equilibrated with 30 mM phosphate buffer, pH 6.5, 5.5 mS/cm 
conductance. Cytc bound to the CM52 column was oxidized on the column with 2 mM 
K3Fe(CN)6, and was eluted by step gradient using 30, 50, 80, 120, and 150 mM 
phosphate buffers, pH 6.5. To obtain a highly pure fraction of Cytc, the DE52 and CM52 
ion exchange chromatography steps were repeated. For further purification HPLC size-
exclusion chromatography, with a column equilibrated with 150 mM phosphate buffer, pH 
6.5, was performed and a mixture of phosphorylated and nonphosphorylated Cytc was 
obtained. The protein was concentrated under vacuum, desalted by centrifugation using 
Amicon Ultra-15 3kDa centrifugal filter units (Millipore, Billerca, MA), and stored at -80ºC. 
2.2.19 Protein concentration and purity determination 
                Purified Cytc was reduced with 100 mM sodium dithionite, desalted with NAP-
5 columns (GE Healthcare, Piscataway, NJ), and analyzed on a Jasco V-570 double 
beam spectrophotometer (2 nm band width). The concentration was determined by 
differential spectra at 550 nm by subtracting the oxidized form from the reduced and 
calculated via ɛ(red.–ox.)550 nm=19.6 mM−1 cm.−1 Purity of the protein was confirmed by 
Coomassie staining after 12% Tris-Tricine SDS PAGE. 
2.2.20 Gel electrophoresis and Western blotting 
                Western analyses were performed to analyze the phosphorylation status of 
purified Cytc, with a 1:5000 dilution of primary antibodies: anti-phospho tyrosine (4G10, 
Millipore, Bilerica, MA), anti-phosphoserine (set of four individual monoclonal antibodies, 
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1C8, 4A3, 4A9, and 16B4, EMD Biosciences, Gibbstown, NJ), and anti-phosphothreonine 
antibodies (set of three individual monoclonal antibodies, 1E11, 4D11, and 14B3, EMD 
Biosciences, Gibbstown, NJ) followed by a 1:10,000 dilution of anti-mouse IgG or IgM 
horseradish peroxidase conjugated secondary antibody (GE Healthcare). EGF-
stimulated A431 total cell lysate (Upstate, Bilerica, MA) was used as a positive control 
and ovalbumin as a negative control. Signal detection was performed with an enhanced 
chemiluminescence method (GE Healthcare, Piscataway, NJ). The following antibodies 
were used at a dilution of 1:1,000: complex I NDUFB6 (MS108, MitoSciences, Eugene, 
OR); complex II 70kD subunit (MS204, MitoSciences, Eugene, OR); complex III core I 
(MS303, MitoSciences, Eugene, OR); complex IV Subunit I (MS404; MitoSciences, 
Eugene, OR); complex IV subunit IV (sc58348, Santa Cruz Biotechnology, Dallas, TX); 
cytochrome c (556433, BD Pharmingen, San Jose, CA); porin (MSA03, MitoSciences, 
Eugene, OR); and GAPDH: (ab9484, Abcam). To separate Thr28-phosphorylated from 
unphosphoryated Cytc a 15% acrylamide/2.6% bisacrylamide gel (Tris-tricine-SDS 
PAGE) was prepared. Cytc (500 ng) was denatured in 2x sample buffer (NuPAGE, 
NP0007, Invitrogen) with 100 mM DTT and 3% mercaptoehanol. Anode and cathode 
buffers were 0.2 M Tris pH, 8.9 and 100 mM Tris, 100 mM Tricine, 0.1% SDS, pH 8.25) 
and gels were run at a low voltage (80 V) for up to 4 h. 
2.2.21 Mutagenesis, expression, and purification of cytochrome c variants 
                Mouse somatic Cytc cDNA was cloned into the pLW01 expression vector (kind 
gift from Dr. Lucy Waskell, University of Michigan) that also contained the cDNA encoding 
heme lyase (CYC3), an enzyme necessary for the covalent attachment of the heme group 
to apo-Cytc. Threonine 28 (Thr28) in the wild type Cytc cDNA was mutated to the 
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phosphomimetic glutamate and nonphosphorylatable alanine as an additional control. 
Forward primers 5'-AAGCATAAGGAGGGACCAAA-3' (Tm=53.8C) and 5'-
AAGCATAAGGCTGGACCAAA-3' (Tm=53.8C) and corresponding reverse and 
complement primers 5'-TTTGGTCCCTCCTTATGCTT-3' (Tm=54.6C) and 5'-
TTTGGTCCAGCCTTATGCTT-3' (Tm=54.6C) were used for Thr28Glu and Thr28Ala 
mutagenesis PCR, respectively. The outer primers that amplified the entire Cytc cDNA 
sequence containing NcoI and BamHI restriction sites were 5'-
AATTTACCATGGGTGATGTTGAAAAAG-3' (Tm=56.7C) and 5'-
AATAAAGGATCCAGTGGAATTATTCAT-3' (Tm=54.7C), respectively. The mutated 
Cytc cDNA sequences were subcloned into the pLW01 bacterial expression plasmid after 
restriction digestion with NcoI and BamHI. Note that the Cytc cDNA contains an internal 
NcoI restriction site; thus the fragments were first fully digested with BamHI following 
partial (3 min) digestion with NcoI and purification of the correct size fragment after 
agarose gel electrophoresis. Constructs were confirmed by sequencing and used to 
transform competent E. coli C41 (DE3) cells for protein overexpression 75. The clones 
were inoculated into 20 mL TB medium (Difco, BD, Franklin Lakes, NJ) containing 100 
μg/mL carbenicillin and grown overnight at 37ºC under shaking. These cultures were used 
to inoculate 4 L of 100 μg/mL carbenicillin-containing TB medium and were grown until 
an OD600 of 2-3 was reached. At this time, the expression of cytochrome c was induced 
by addition of 100 mM isopropyl β-D-1-thiogalactopyranoside (IPTG), and the protein was 
overexpressed for 6 h at 37ºC. The cells were harvested by centrifugation for 40 min at 
8,400 x g, 4ºC, and the pellets were immediately stored at -80ºC until used for Cytc 
extraction. The bacterial pellets were resuspended in lysis buffer containing 20 mM 
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phosphate buffer, pH 7.4 supplemented with a protease inhibitor cocktail (P8340, Sigma) 
as recommended by the manufacturer. For every 10 g of bacterial pellet 100 ml of lysis 
buffer were used and the resuspended cells were lysed using a French Pressure Cell 
Press (American Company, Aminco). The lysates were centrifuged at 15,000 rpm for 45 
min, the pH of the supernatant was adjusted to 7.4 and Cytc variants were purified by ion 
exchange chromatography as described above for kidney Cytc isolation. For expression 
of Cytc variants in Cytc double knockout mouse lung fibroblasts the pBABE-puro 
expression plasmid (Addgene, Cambridge, MA) was used. A similar PCR mutagenesis 
approach was performed as above and fragments were cloned into the BamHI and EcoRI 
restriction sites using the primers outer forward primer pBABE 5’-
ATCTTGTGGAAAGGACGCGGGATCCATGGGTGATGTTGAAAAA-3’ (Tm=68.0C) and 
outer reverse primer pBABE 5'- 
GGTCGACCACTGTGCTGGCGAATTCTTACTTATCGTCGTCATCCTTGTAATCTTCAT
TAGTAGCC-3' (Tm=68.8C). The resultant C-terminal 1XFLAG-tagged wild-type, 
Thr28Glu phosphomimetic mutant, and Thr28Ala non-phosphorylatable mutant 
constructs were transfected into Cytc double knockout lung fibroblast cells and cultured 
in DMEM media (high glucose, Gibco BRL), supplemented with 10% fetal bovine serum, 
1000 units penicillin/streptomycin, 1mM pyruvate, 50 g/mL uridine at 37°C and 5% CO2. 
Stable cell lines expressing the three Cytc variants as well as an empty vector control cell 
line were selected in the presence of 4 µg/mL puromycin.  
2.2.22 Circular dichroism spectroscopy 
                Circular dichroism (CD) spectra of cytochrome c variants (wild type, Thr28Ala, 
Thr28Glu, and bovine heart cytochrome c (Sigma)) were recorded on a Jasco J-815 
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spectrometer using a 0.6 mm path length quartz cuvette. Proteins were diluted to 220 μM 
final concentration in 100 mM phosphate buffer, pH 7.4, and 1 mL protein solution was 
reduced with 250 μM ascorbate. An average of 3 scans were collected at 20°C at a 
resolution of 1 nm. 
2.2.23 Crystallization of WT, T28A, and T28E cytochrome c, and data analysis 
                Cytc was gel-filtered on a S100 column to reduce aggregates and concentrated 
to 15 mg/mL or higher in water. To establish a defined oxidation state, the proteins were 
oxidized with 5 mM K3Fe(CN)6 prior to crystallization. Crystals were grown by vapor 
diffusion after mixing 1 L of protein solution with 1L of precipitant solution and 
equilibrating the drop against 0.5 mL of the precipitant at room temperature. The 
respective precipitant solutions for crystals of the WT, T28A, and T28E Cytc are listed in 
Supplemental Table 1. Crystals usually appeared within 1 week. Crystals were soaked 
for 10 minutes in a cryo-protectant solution (Supplemental Table 1) before flash freezing 
in liquid nitrogen. Single crystal diffraction data were collected at the Life Sciences 
Collaborative Access Team facility (Advanced Photon Source sector 21, Argonne 
National Laboratory). The data were collected over a full 360° rotation in either 0.6 or 1.0 
degree frames and integrated using XDS 85 in AutoProc 86. For structure solution and 
refinement the native data set was solved using chain-A of the human Y48F Cytc structure 
(3ZOO.pdb) in PHENIX 78. It was refit with AutoBuild in the PHENIX suite and refined with 
PHENIX initially to get occupancies for the FC6 molecules. The refinement was 
completed with Refmac5 in CCP4 using refinement parameters and weights optimized 
with PDB_REDO. In particular, PDB_REDO recommended anisotropic temperature 
factors based on the Hamilton ratio test for all three structures. Electron density was 
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analyzed with COOT 87 in the CCP4 suite of crystallographic programs 88. The FC6 
ligands were located and placed in an anomalous diffraction difference map with COOT. 
Using the WT structure as an example, the highest 8 peaks - in order - in the map, are 
the 4 heme iron atoms, followed by FC6 202/C, FC6 202/B, FC6 202b/A, and FC6 203b/B. 
The next 3 peaks are for three sulfur atoms (Cys14/A, Cys17/B, Met80/D) followed by 
FC6 202a/A and FC6 202a/B. The last two FC6 positions were included because they 
had sufficient 2Fo-Fc density to fit several of their cyanide groups. 
2.2.24 Molecular dynamics and ESP calculations 
                Molecular dynamics were performed with YASARA 89 using its conservative 
“slow” protocol and the recommended default force field, AMBER 2003 90. The Root Mean 
Square Fluctuations (RMSF) and average structures plotted in Figure 3 were calculated 
with default scripts in the YASARA library. Electrostatic potentials (ESP) in vacuo were 
calculated with YASARA to highlight the charge distribution using the recommended 
NOVA force field 91 and the Particle Mesh Ewald algorithm 92. The rectangular simulation 
cell for the ESP calculations was 15Å from all atoms in the tetramer. No ligands were 
included in the calculation. Molecular images including the superpositions were calculated 
in YASARA 89. Plots were generated with Excel using data imported from YASARA. The 
three electron density plots in Figure 3 were assembled with PyMOL (The PyMOL 
Molecular Graphics System, Version 1.8 (2015) Schrödinger, LLC) using electron density 
calculated by COOT. The final assembly of all figures was done in Photoshop. 
2.2.25 Cytochrome c oxidase (CcO) activity measurements 
                Briefly, an aliquot of regulatory competent bovine liver CcO, which has the 
same isozyme complement as kidney CcO, was diluted to 3 μM final concentration in the 
27 
 
presence of a 40-fold molar excess of cardiolipin and 0.2 mM ATP in CcO measuring 
buffer (10 mM K-HEPES (pH 7.4), 40 mM KCl, 1% Tween 20) and dialyzed overnight at 
4ºC to remove cholate bound to CcO during enzyme purification. Respiration of CcO (150 
nM) was analyzed in a closed chamber equipped with a micro Clark-type oxygen 
electrode (Oxygraph system; Hansatech, Pentney, UK) at 25ºC in 220 μL of CcO 
measuring buffer and 20 mM ascorbate as electron donor. Increasing amounts of purified 
Cytc variants (0-25 μM) were added, and oxygen consumption was recorded and 
analyzed with the Oxygraph software (Hansatech). CcO activity was expressed as 
turnover number (TN; sec-1). 
2.2.26 Caspase 3 activation by Cytc variants 
                Cells from eight 150 mm plates were collected by centrifugation at 4ºC. The 
pellet was washed once in 5 mL of ice cold cytosol extraction buffer (20 mM HEPES, pH 
7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM 
PMSF), resuspended gently in the same buffer, and immediately transferred to an ice 
cold dounce homogenizer. After 15 min of swelling on ice cells were then broken open 
with a B-type glass pestle, and cell breakage confirmed using a microscope. The lysates 
were transferred to microcentrifuge tubes and centrifuged at 4ºC and 15,000 x g for 15 
min to remove nuclei and other debris. The protein concentration of the cytosolic fraction-
containing supernatant was measured using the DC Assay kit (Bio Rad, Hercules, CA) 
and cytosolic extracts were diluted to 2 mg/mL. EnzChek Caspase-3 assay kit (Invitrogen, 
Carlsbad, CA) with rhodamine 110-linked DEVD tetrapeptide, an artificial substrate for 
caspase 3 that fluoresces upon cleavage, was used. Cytosolic extracts from Cytc double 
knockout lung fibroblast cells (2 mg/mL concentration) were incubated with the Cytc 
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variants (15 µg/mL) for 2.5 h at 37ºC. Caspase 3 activity was assessed in the presence 
or absence of the caspase 3 inhibitor by detection of fluorescence from the cleavage of 
the artificial caspase 3 substrate over 3 h in 30 min intervals using a Fluoroskan Ascent 
FL plate reader (Labsystems, Thermo Scientific, Waltham, MA), 485 nm excitation filter 
(14 nm band width) and 527 nm emission filter (10 nm band width). Amount of cleaved 
substrate was calculated from the rhodamine 110 calibration curve, and data were 
expressed in pmol of DEVD3 min-1 (mg protein)-1.  
2.2.27 Measurement of Cytc redox potential 
                The midpoint redox potential (E0’) was analyzed spectrophotometrically as 
described 75 using 2, 6 dichloroindophenol (DCIP, E0’=237 mV) as a reference compound, 
which has an absorption band at 600 nm in its oxidized state. One mL of Cytc solution (2 
mg/mL) was mixed in a spectrophotometric cuvette with 2 mL of 50mM citrate buffer, pH 
6.5, 0.1 mL of 1 mM DCIP, and 50μL of 1 mM K3Fe(CN)6 to fully oxidize Cytc. 
Absorbances corresponding to fully oxidized Cytc (A550-A570) and DCIP (A600) were 
recorded using a Jasco V-570 double beam spectrophotometer. The mixture was then 
sequentially reduced by 1 μL additions of 5 mM ascorbate (pH 6.5), and absorbance 
values were acquired at each step. When readings became constant, a few grains of 
sodium dithionite (Na2S2O4) were added to fully reduce Cytc and DCIP. For each step, 
ratios of oxidized and reduced forms of both compounds were calculated. Data obtained 
were plotted as log(DCIPOX/DCIPRED) versus log(CytOX/CytRED), yielding a linear graph 
with a slope of n-DCIP/n-Cytc and a y-axis intercept of n-Cytc / 59.2(E Cytc – E DCIP). 
These values were used to calculate the E0’ (mV) of Cytc from the Nernst equation. 
2.2.28 Measurement of rates of oxidation and reduction 
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                The kinetics of oxidation of 15 µM ferro-Cytc with 100 µM H2O2 and reduction 
of 15 µM ferri-Cytc with 200 µM ascorbate was measured spectrophotometrically at 550 
nm as described 55. Briefly, WT Cytc and T28E and T28A Cytc mutants were reduced 
with sodium dithionite, and the proteins separated from the reductant through NAP5 
columns. Fifteen µM Cytc in 0.2 M Tris-Cl, pH 7.0 were incubated with 100 µM oxidizing 
agent H2O2 and after 10 sec, the decrease of the absorption peak at 550 nm was 
measured, and the amount of oxidized Cytc was calculated as described above. To 
measure the kinetics of reduction of Cytc with ascorbate, Cytc variants were fully oxidized 
with K3Fe(CN)6 and purified using NAP5 columns. Fifteen µM ferri-Cytc was added to 50 
mM sodium phosphate, 25 mM sodium dithionite (Na2SO4), pH 7.0 and 200 µM ascorbate 
to a cuvette, which was then sealed from air, and the initial rate of reduction was 
measured at 550 nm.  
2.2.29 Heme degradation assay 
                The degradation of heme was analyzed through dissipation of the Soret band 
at 408 nm using 5 µM ferri-Cytc from in 50 mM phosphate buffer, pH 6.1 with 3 mM H2O2 
as described 55. Spectra were scanned initially after 60 seconds followed by 
measurements every 200 seconds. 
2.2.30 Measurement of mitochondrial oxygen consumption rate tissue 
homogenates 
                Respiration of intact mitochondria in tissue homogenates was determined as 
described 83, using freshly harvested kidney tissues following treatment with AMPK 
activator and inhibitor as above, following homogenization in homogenization buffer with 
ten strokes. The protein concentration was determined using the DC protein assay kit 
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(Bio-Rad)., and diluted to 0.2 mg/mL with KCl buffer (80 mM KCl, 10 mM Tris–HCl, 3 mM 
MgCl, 1 mM EDTA, 5 mM potassium phosphate, 2.5 mM malate, 0.5 mg/ml BSA, pH 7.4). 
Mitochondrial respiration was measured at 30ºC using a Clark-type oxygen electrode as 
described above. 
2.2.31 Tissue Treatments with AMPK activator A-769662 and inhibitor Compound 
C 
                Wild-type male mice, 2-4 months old littermates, were housed at 23°C under 
12hr:12hr light:dark periods. Animals were euthanized following NIH guidelines and 
immediately after the animals died their kidneys taken out and placed in ice cold ST buffer 
containing 250 mM sucrose, 20 mM Tris, pH 7.4, 10 mM KF, 1 mM PMSF, 1 mM sodium 
orthovanadate, supplemented with protease inhibitor cocktail (Sigma) and phosphatase 
inhibitor cocktails 2 (P5726, Sigma) and 3 (P0044, Sigma) according to manufacturer’s 
protocol. Kidneys were then minced with scissors on an ice cold glass plate and equal 
weight (80 mg) placed in tubes containing 2 ml buffer following treatment with either 500 
µM A769662 (AMPK activator, Tocris, #3336), 3 µM Compound C (AMPK inhibitor, 
Sigma, P5499), or DMSO (no treatment control) for 1 h at 37ºC under shaking. Tubes 
were put on ice, tissues pelleted by centrifugation, and buffer replaced with 1 mL 
homogenization buffer (50 mM Tris-Cl, pH 7.5, 1 mM EGTA, 1% Triton-X 100, 1 mM 
sodium orthovanadate, 50 mM KF, 5 mM sodium pyrophosphate, 0.27 M sucrose, 0.1% 
-mercaptoethanol, supplemented with protease inhibitors and phosphatase inhibitor 
cocktails as above, and homogenized using a Teflon dounce homogenizer by applying 
60 strokes. Homogenates were centrifuged at 22,000 x g at 4ºC for 30 min and 
supernatants' total protein levels were quantitated using the DC protein assay kit (Bio-
Rad).. Twenty g tissue homogenates were loaded for immunoblot analyses to check for 
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total and phospho AMPK levels and phospho-acetyl CoA carboxylase (p-ACC) levels 
(AMPKα1/2 antibody (H-300), sc-25792; p-AMPKα1/2 antibody (Thr 172), sc-33524, 
Santa Cruz Biotechnology, Dallas, Texas, USA; p-Acetyl-CoA Carboxylase (Ser79) 
antibody #3661, Cell Signaling Technology, Danvers, MA, USA; antibody dilution 
1:1000). Subsequently, 1 mg homogenate was used for overnight immunoprecipitation of 
Cytc. A 10% Tris-tricine-SDS PAGE was run to analyze total and phospho AMPK levels, 
phospho-ACC levels, and threonine phosphorylation of immunoprecipitated Cytc (using 
a 1:250 dilution of a set of three individual monoclonal anti-phosphothreonine antibodies, 
1E11, 4D11, and 14B3, EMD Biosciences, Gibbstown, NJ). In addition, AMPK was 
immunoprecipitated from kidney homogenates after treatment with 500 µM A769662 for 
1 h to analyze Cytc co-immunoprecipitation. 
2.2.32 Sucrose-density gradient isolation of mitochondria and subfractionation  
                Lung fibroblasts were harvested and resuspended in 10 mM NaCl, 1.5 mM 
MgCl2, 10 mM Tris-Cl, pH 7.5. They were allowed to swell for 5 min on ice, and 
homogenized using a Teflon-glass homogenizer. The sucrose concentration was 
adjusted to 250 mM by adding 2 M sucrose and TE buffer (10 mM Tris-Cl, 20 mM EDTA, 
pH 7.6). The homogenate was centrifuged twice at 1,300 x g for 3 min, the supernatant 
collected and centrifuged at 15,000 x g for 10 min, and washed three times with 250 mM 
sucrose/TE buffer. The mitochondrial fraction was layered on a discontinuous sucrose 
gradient containing 1M sucrose and 1.7 M sucrose in TE buffer. Centrifugation was 
performed at 70,000 x g for 40 min at 4ºC and mitochondria retrieved from the interface. 
Mitochondria were washed in 250 mM sucrose/TE buffer and collected by centrifugation 
at 22,000 x g for 15 min to obtain highly pure mitochondria. The mitochondrial pellet was 
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resuspended in 20 mM sodium phosphate buffer, pH 7.2, 0.02% BSA, and allowed to 
swell for 20 min on ice, then 1 mM ATP and 1 mM MgCl2 were added, followed by 
incubation on ice for 5 min, and centrifugation at 15,000 x g for 10 min at 4ºC. The 
supernatant contained the intermembrane space fraction and the pellet contained 
mitoplasts, the outer membrane fraction, and residual intermembrane space fraction. 
2.2.33 Isolation and subfractionation of mitochondria from mouse kidneys 
                Mouse kidneys were freshly harvested and washed in ice-cold isolation buffer 
(10 mM Tris, 1 mM of EGTA/Tris, 200 mM sucrose, pH 7.4 adjusted with MOPS) 84. 
Kidneys were minced with scissors on an ice-cold glass plate and homogenized with 20 
strokes using a dounce homogenizer on ice. The homogenate was centrifuged at 600 x 
g for 10 min and the supernatant centrifuged at 7,000 x g for 10 min to pellet mitochondria. 
The mitochondrial pellet was subfractionated into an intermembrane space fraction and 
a mitoplast and outer membrane fraction as described above. 
2.2.34 ATP assay 
                Lung fibroblast cells expressing Cytc variants were scraped and collected and 
immediately stored at -80ºC until measurement. Release of ATP was performed by boiling 
method after addition of 300 μL of boiling buffer (100 mM Tris-Cl, pH 7.75, 4 mM EDTA), 
and immediate transfer of the samples to a boiling water bath for 2 min. Samples were 
put on ice, sonicated, diluted 300-fold, and 40 μL of the diluted samples were used to 
determine the ATP concentration with the ATP biolumescence assay kit HS II (Roche, 
Indianapolis, IN) according to the manufacturer's protocol. Data were standardized to the 
protein concentration using the DC protein assay kit (Bio-Rad). 
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2.2.35 Measurement of the mitochondrial membrane potential (ΔΨm) 
                Lung fibroblast cells expressing Cytc variants were grown to 80% confluence. 
To assess relative changes in mitochondrial membrane potential (ΔΨm), cells were 
incubated for 30 min in phenol red-free medium containing 1 μM JC-1 (Molecular Probes). 
JC-1 is able to selectively enter mitochondria, is a monomer at low concentration or at 
low membrane potential, and emits green fluorescence. At higher membrane potential 
JC-1 forms aggregates that emit red fluorescence. Cells were washed with PBS and 
fluorescence measured with an Ascent Fluoroskan plate reader by using an excitation 
wavelength of 485 nm and an emission wavelength of 590 nm for red aggregates and 
527 for green monomers. 
2.2.36 Cell viability 
                Cells (100,000 per well in six-well plates) expressing Cytc variants were and 
grown for 48 h, trypsinized, and live cells were counted after staining with trypan blue. 
For cell viability analyses after treatment with H2O2, cell number was doubled and cells 
were treated with 50 µM and 300 µM H2O2 for 24 h followed by trypan blue staining. 
2.2.37 Statistical analyses 
                Statistical analyses were performed using MSTAT version 5.4 (N. Drinkwater, 
University of Wisconsin) in conjunction with the Wilcoxon rank-sum test. Data (n=3-4) are 
reported as means ±SD and were considered statistically significant (*) with p<0.05. 
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2.3 Results 
2.3.1 Mammalian kidney cytochrome c is phosphorylated on Thr28 leading to 
‘controlled’ respiration. 
                To test if Cytc phosphorylation occurs in mammalian tissues other than heart 
and liver, where it is tyrosine phosphorylated, we chose kidney, an organ with a high 
mitochondrial capacity and the second highest oxygen consumption rate only after heart 
93. Surprisingly, Western analysis of Cytc from bovine kidney detected phosphorylation 
on threonine (Figure 1A) but not on tyrosine (not shown). Mass spectrometry 
unambiguously revealed that Thr28 was phosphorylated in three independent Cytc 
isolations analyzed (Figure 1B). This amino acid is conserved in mammals, both in the 
somatic and testes-specific isoform (Supplemental Figure 1A). To test the effect of Thr28 
phosphorylation we measured the kinetics of Cytc with isolated CcO. Oxygen 
consumption rate was 50% lower at maximal turnover for Thr28 phosphorylated versus 
unphosphorylated Cytc (Figure 1C). Phosphorylation of Thr28 also dropped the apparent 
KM of Cytc in the reaction with CcO from 6.3 to 4.5. Similar to Tyr48 and Tyr97 
phosphorylation, Thr28 phosphorylation leads to partial inhibition of respiration, or 
‘controlled respiration,’ which we propose prevents m hyperpolarization and thus ROS 
production under non-stressed conditions. In order for a posttranslational modification 
(PTM) to be biologically relevant a significant fraction of the protein should carry the 
modification. Using high resolution gel electrophoresis which separates phosphorylated 
and unphosphorylated Cytc we found that over 80% of the Cytc pool was phosphorylated 
(Figure 1D).  
2.3.2 Overexpression and purification of functional and correctly folded 
cytochrome c variants in E. coli cells 
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                We and others have previously shown for tyrosine phosphorylated Cytc that 
phosphomimetic replacement of the phosphorylatable residue with the negatively 
charged glutamate produces functional effects similar to those seen with the in vivo 
phosphorylated protein 75,94. This approach has the advantage that large amounts of the 
phosphomimetic Cytc can be overexpressed in bacteria and purified, and that the 
negative charge introduced through the glutamate residue is stable whereas attached 
phosphates may be lost during assays that require prolonged incubation periods or 
contain cytosolic extracts that contain phosphatases. We thus generated the following 
Cytc variants based on the mouse sequence and overexpressed them in E. coli BL21 
(DE3) cells: WT, phosphomimetic Thr28Glu, and Thr28Ala Cytc as additional control, 
which cannot be phosphorylated. Cytc variants were purified using a French press 
followed by anion and cation ion-exchange chromatography. Purity of Cytc was confirmed 
by Coomassie staining (Figure 2A) and spectrophotometric analysis, with 410 nm/280 nm 
ratios >4 75. All three proteins were fully reducible and correctly folded as shown by 
absorption spectra measurements (Supplemental Figure 1B) and circular dichroism 
(Supplemental Figure 1C). Similar to our previous study 75, none of the bacterially 
overexpressed proteins were Ser-, Thr-, or Tyr-phosphorylated (not shown). The redox 
midpoint potential of Cytc is approximately midway between the redox potentials of 
complexes III and IV, and values reported in the literature range from 220 and 270 mV 95. 
We analyzed the redox midpoint potential spectrophotometrically by the equilibration 
method using 2,6-dichloroindophenol as the reference compound. The redox potentials 
for WT, Thr28Ala, and Thr28Glu were 246 mV, 221 mV, and 217 mV (Figure 2B), 
36 
 
suggesting that a modification on position 28 can lower the redox potential of Cytc, similar 
as we have reported for phosphomimetic Tyr48Glu Cytc 75.  
 
 
Figure 1. Kidney cytochrome c is phosphorylated on threonine 28 leading to 
controlled respiration. 
(A) Purification of cow kidney Cytc indicates threonine phosphorylation. Lane 1, kidney 
Cytc; lane 2, cow heart Cytc (Sigma); lane 3, ovalbumin (Western negative control); lane 
4, EGF treated cell extract (Western positive control). Top, Coommassie gel; bottom anti-
phospho-Thr Western blot. 
(B) Nano-LC/ESI/MS/MS spectrum of HKpTGPNLHGLFGR reveals phosphorylation of 
Thr28. The phosphorylation site was unambiguously assigned by fragment ions y10 and 
y11. The sequence of the peptide was assigned by b2, b8, b9, y1, y2, y4, y5, y6, y8, y9, 
and y10.  
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(C) In vitro cytochrome c oxidase activity with in vivo phosphorylated pThr28 (pT28) is 
50% reduced at maximal turnover compared to unphosphorylated Cytc.  
(D) High resolution gel electrophoresis indicates that 83% of the Cytc pool is 
phosphorylated (lane one, upper band). Lane 2, unspecific phosphatase treatment of Cytc 
collapses the upper band. 
 
2.3.3 Phosphomimetic cytochrome c displays a significantly decreased reaction 
rate with isolated cytochrome c oxidase (CcO) 
                We showed that in vivo phosphorylated Cytc displayed an approximately 50% 
inhibition in the reaction with isolated bovine liver CcO (Figure 1C). To demonstrate that 
Thr28Glu is a good model for Thr28 phosphorylated Cytc we first analyzed its activity in 
the reaction with purified CcO. As shown in Figure 2C, we found that respiration rates of 
phosphomimetic Thr28Glu and Thr28Ala Cytc were 73% and 51% reduced, respectively, 
indicating that Thr28Glu Cytc serves as a useful model. The apparent KM of Cytc in the 
reaction with CcO was 7.8, 9.3, and 4.7 for unphosphorylated WT, Thr28Glu, and 
Thr28Ala Cytc, respectively. The fact that the inhibitory effect of the phosphomimetic 
substitution is even more pronounced than that observed with in vivo phosphorylated Cytc 
may be due to the subfraction (about 20%) of unphosphorylated Cytc present when 
isolated from kidneys. 
2.3.4 Thr28Glu cytochrome c is capable to trigger caspase-3 activation but shows 
distinct features in its ROS-related functions 
                To test the possible effect of Thr28 phosphorylation on apoptotic function, we 
analyzed the ability of the Cytc variants to trigger apoptosis by measuring downstream 
activation of caspase-3 using a cell-free caspase assay. Cytc mutants were incubated 
with cytosolic fractions prepared from mouse lung fibroblasts in which both the somatic 
and testes-specific isoforms of Cytc were knocked out 77. The Thr28Glu mutant was able 
to activate caspase-3 similar to wild-type Cytc protein (Figure 2D) and Thr28-
phosphorylated Cytc (Supplemental Figure 2), indicating that Thr28 phosphorylation of 
38 
 
Cytc does not affect the function of Cytc at the level of apoptosome formation. Other 
functions of Cytc include ROS scavenging, such as reduction by superoxide to regenerate 
oxygen or oxidation by H2O2. We therefore tested the ability of Cytc in the reaction with 
H2O2 and with the reductant ascorbate. To analyze the former, ferro-(Fe2+)-Cytc variants 
were oxidized in the presence of 100 µM H2O2. The Thr28Glu phosphomimetic mutant 
was oxidized at a rate similar to WT Cytc, while Thr28Ala mutant was oxidized at a 2.7-
fold higher rate (Figure 2E). At higher ROS load Cytc can lose its functionality through 
oxidative modifications, which can be monitored through a decrease in the absorption of 
the heme Soret band at 408 nm present in intact Cytc. After addition of excess H2O2 (3 
mM) Thr28Glu Cytc was more resistant to degradation by excess H2O2 than the wild-type, 
while the Thr28Ala mutant was degraded more rapidly (Figure 2F), suggesting that the 
introduction of a negative charge in position 28 stabilizes the protein. To determine the 
rate of Cytc reduction, ferri-(Fe3+)-Cytc variants were reduced in the presence of 200 µM 
ascorbate. Thr28Glu Cytc was reduced at about twice the rate compared to WT and 
Thr28Ala Cytc (Figure 2G), suggesting that it can act as a superior electron acceptor and 
scavenger.  
                Cardiolipin (CL) oxidation is a pro-apoptotic function of Cytc. Native Cytc 
possesses a low degree of peroxidase activity, which increases when CL binds to Cytc 
causing partial unfolding 96. To assess peroxidase activity of Cytc, the rate of Amplex Red 
oxidation by CL-peroxide was analyzed in the presence of H2O2. H2O2 is a poor substrate 
for Amplex Red oxidation whereas oxidized CL species are good substrates. At higher 
tetralinoleyl-CL(TOCL)/Cytc ratios Thr28Glu Cytc showed significantly reduced 
peroxidase activity compared to WT (Figure 2H). Interestingly, the Thr28Ala mutant had 
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the highest peroxidase activity at all ratios, suggesting that it unfolds more easily 
compared to WT and Thr28Glu Cytc.  
2.3.5 High resolution X-ray crystallography and molecular dynamics reveal 
structural features of the Thr28 epitope.  
                In order to gain a better understanding of the structure-function relationship of 
the Thr28 epitope we crystalized all three mouse Cytc variants under oxidizing conditions 
and obtained crystals that diffracted at a resolution of 1.12 Å, 1.36 Å, and 1.30 Å for WT, 
Thr28Ala, and Thr28Glu Cytc. The WT structure has the highest resolution of any 
mammalian Cytc structure. As expected, the crystal structures of WT, Thr28Ala and 
Thr28Glu are overall similar (Figure 3A, D, and G and Supplemental Table 1). To explore 
possible differences in their solution structures, molecular dynamics simulations were 
performed on the A-chain from the three protein structures as well as on a model of 
phosphorylated Cytc with the phosphate group added to Thr28 in the WT chain-A using 
-chain from the final solution 
structure after 200 ns superposed well with the beginning crystal structure except for the 
Thr28-containing loop 22-30 (Fig. 3: A, B, D, E, G, H, J, and K), which also had the highest 
root mean square fluctuations (RMSF) except for the N- and C-termini (Figure 3C, F, I, 
and L). In all 4 simulations, the surface loop adopted an alternate conformation, which 
moved the C atom of residue 28 about 5 Å from its starting position. Surprisingly, in the 
Thr28Ala simulation, the loop paused at the same conformation as the others but then 
continued to move until it reached a conformation after 200 ns that put Ala28 11.9 Å from 
its starting position (Figure 3E). These differences may explain the structural instability of 
this mutant. In contrast Thr28Glu Cytc recapitulates the functional effects seen with in 
vivo phosphorylated Cytc. As expected, electrostatic potential (ESP) calculations show 
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that the Thr28Glu mutant has a negative ESP region that is larger than WT and only 
exceeded by the Thr28Tpo model (Supplemental Figure 4B, C, and D). 
2.3.6 Introduction of Thr28Glu cytochrome c into cytochrome c double knockout 
cells reduces oxygen consumption rate, the mitochondrial membrane potential, 
and ROS. 
                To test the effect of phosphomimetic substitution of Cytc on mitochondrial 
parameters in intact cells we generated stably transfected cell lines, transfected with 
empty vector (EV) control and WT, Thr28Glu, and Thr28Ala Cytc, using mouse lung 
fibroblast in which both the somatic and testes-specific Cytc isoforms have been knocked 
out. Double knockout is required since cultured cells lacking somatic Cytc induce the 
expression of the testes isoform, restoring mitochondrial respiration 77. Expression levels 
of WT and Thr28Glu Cytc were comparable between different clones whereas protein 
levels of Thr28Ala Cytc was less compared to the other Cytc variants (the clone with the 
highest expression levels was used for subsequent experiments, Figure 2I), suggesting 
that higher expression levels of this mutant may interfere with cellular functions or that 
protein turnover is higher. As previously reported, Cytc knockout interferes with complex 
I and IV assembly 97, which is reduced upon reintroduction of the three Cytc variants 
(Figure 2I). Determination of cell growth showed that WT and Thr28Glu Cytc expressing 
cells grew equally well whereas Thr28Ala Cytc expressing cells showed a 27% reduced 
growth rate versus WT (Fig. 2J) (see Discussion). We first analyzed intact cell respiration. 
Strikingly, cells expressing Thr28Glu phosphomimetic Cytc showed 60% reduced 
respiration rates (Figure 2K) matching those results obtained with purified CcO in vitro 
(Figures 1C and 2C). This finding is of importance because it suggests that a modification 
of the small electron carrier Cytc can control overall flux in the ETC, a scenario that has 
not been reported or considered in the past. Consequently, a reduction of the respiration 
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rate should translate into a reduced mitochondrial membrane potential m. Analysis with 
the voltage-dependent probe JC-1 showed that Thr28Ala and Thr28Glu expressing cells 
showed 15% and 31% reduced fluorescence compared to WT (Figure 2L), indicating a 
reduction of m. Given the direct connection of m with ROS production at complexes 
I and III 98, we predicted that Thr28Glu expressing cells should exhibit reduced ROS 
levels. Using the mitochondrial ROS probe MitoSox we found that fluorescent signals 
were reduced by 35-40% in cells expressing Thr28Glu and Thr28Ala Cytc compared to 
WT, indicating reduced ROS levels (Figure 2M). ATP levels were reduced by 6% and 
28% for cells expressing Thr28Ala and Thr28Glu, respectively (Figure 2N). To test if cells 
expressing Thr28Glu Cytc are better protected from H2O2 exposure, cell viability was 
determined after treatment with H2O2. Thr28Glu Cytc expressing cells showed higher 
viability when treated with low concentration of H2O2, but viability matched with WT Cytc 
expressing cells at higher H2O2 concentration (Figure 2O). This observation suggests that 
Thr28Glu Cytc protects the cells from mild oxidative stress. These data suggest that 
modification of Cytc Thr28 regulates ETC flux, which in turn affects m and ROS. 
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Figure 2. Phosphomimetic Thr28Glu cytochrome c shows unique features in vitro 
and after reintroduction into cytochrome c double knockout cells. 
(A) Coomassie gel of bacterially overexpressed and isolated wild-type (WT), Thr28-
phosphorylated Cytc (pT28), Thr28Glu (T28E), and Thr28Ala (T28A) Cytc indicates that 
the proteins were purified to homogeneity. 
(B) Redox potential is reduced in the Thr28Glu and Thr28Ala mutants compared to WT. 
(C) O2 consumption rates of Cytc in the reaction with cow cytochrome c oxidase were 
73% and 51% reduced for Thr28Glu and Thr28Ala Cytc. 
(D) In vitro caspase 3 activity is unaltered in Thr28Glu Cytc whereas it is increased with 
the Thr28Ala mutant. 
(E) Oxidation rate of WT and Thr28Glu Cytc in the presence of H2O2 is similar whereas 
the Thr28Ala mutant shows increased rates. 
(F) Compared to WT, loss of the heme group by excess H2O2 is decreased and increased 
for Thr28Glu and Thr28Ala Cytc, respectively. Shown are representative heme 
destruction curves. 
(G) Thr28Glu Cytc reduction rate in the presence of ascorbate is increased compared to 
WT and Thr28Ala Cytc. 
(H) Thr28Glu Cytc-mediated cardiolipin oxidation is decreased at highest TOCL/Cytc 
ratios compared to WT and Thr28Ala Cytc. 
(I) Western blot of Cytc double knockout lung fibroblasts stably transfected with empty 
vector (EV) and WT, Thr28Ala, and Thr28Glu expression constructs. 
(J) Proliferation rates of stably transfected lines were determined by cell counts. 
(K) Intact cell oxygen consumption rates (OCR) are decreased in both Cytc mutants. 
(L) Mitochondrial membrane potential as determined by JC-1 fluorescence was 
decreased in cells expressing Thr28Glu versus WT and Thr28Ala Cytc. 
(M) Basal mitochondrial reactive oxygen species generation as determined with MitoSOX 
is decreased in cells expressing Thr28Glu Cytc compared to WT. 
(N) ATP levels determined with the bioluminescent method were decreased in cells 
expressing Thr28Glu Cytc compared to WT. 
(O) Live cell counts after treatment with H2O2 indicate that Thr28Glu expressing cells are 
better protected at intermediate H2O2 levels compared to WT whereas Thr28Ala 
expressing cells show decreased survival at all concentrations. 
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Figure 3. Structural and molecular dynamics analyses. 
(A) Chain-A from the WT crystal structure (5C0Z.pdb) before (green) and after (cyan) 200 
39 intermediate 5 ns steps between the two endpoints are shown as spheres colored in 
a gradient from gray (5 ns) to red (195 ns). 
(B) The mobile loop (amino acids 22-30) from Figure 3A is shown in higher detail after 
rotation by 90° about its horizontal axis to generate a “bottom-up” 
 
atoms (gray to red) all cluster about T28* showing that the loop jumps immediately to its 
minimum energy position and stays there. The distance between T28 C  and T28* C  
is 4.5 Å. 
(C) The root mean square fluctuations (RMSF) for the first 100 ns (blue line) and the 
second 100 ns (red line) by residue are plotted together. Two RMSF values in the first 
100 ns (Lys27, Ala44) are noticeably lower in the second 100 ns. 
(D) Chain-A from the T28A crystal structure (5C9M.pdb) before (green) and after (cyan) 
200 ns of molecular dynamics. See Figure 3A for details.  
(E) Equivalent to Figure 3B except the two loops are from Figure 3D. Over the 200 ns, 
the C  atom of Ala28 pauses at 4 distinct intermediate positions before clustering around 
the final position. The distance between A28 C  and A28* C  is 11.9 Å. 
(F) Equivalent to Figure 3C for T28A Cytc. The RMSF values for Ala44 are lower in the 
second 100 ns but those for Lys27 are significantly higher in the second 100 ns, in fact 
the highest seen in all four RMSF plots. 
(G) Chain-A from the T28E crystal structure (5DF5.pdb) before (green) and after (cyan) 
200 ns of molecular dynamics. See Figure 3A for details. 
(H) Equivalent to Figure 3B except the two loops are from Figure 3G. Over the 200 ns, 
near the end of the simulation. The distance between E28 C  and E28* C  is 7.2 Å. 
(I) Equivalent to Figure 3C for T28E Cytc. The RMSF values for Ala44 are of average size 
and similar for both halves of the simulation. The RMSF values for the loop containing 
Glu28 are higher than average but similar for both halves of the simulation. 
(J) -A from the WT crystal structure (5C0Z.pdb) with a phosphate 
group modeled onto Thr28 are shown superposed before (green) and after (cyan) 200 ns 
of molecular dynamics. See Figure 3A for details. 
(K) Equivalent to Figure 3B except the two loops are from Figure 3J. Over the 200 ns 
period, the C  atom of Tpo28 moves quickly to the final position and clusters around it.  
The distance between X28 C  and XT28* C  is 5.2 Å. 
(L) Equivalent to Figure 3C for the T28PO model. The RMSF values for the loop 
containing Glu28 are higher than average but similar for both halves of the simulation. 
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2.3.7 AMPK interacts with and phosphorylates cytochrome c on Thr28 
                To identify a kinase candidate that targets Cytc for Thr28 phosphorylation we 
first used the online tool Scansite 99 for in silico prediction of possible Cytc binding motifs 
of signaling molecules. Interestingly, Thr28 was predicted to be an AMPK phosphorylation 
site. To test this possibility we first performed an in vitro kinase assay with commercially 
available AMPK and unphosphorylated WT Cytc as substrate to see if this reaction can, 
in principle, take place. As shown in Figure 4A, Cytc was phosphorylated in a specific and 
AMPK-dependent manner, which could be further accelerated by addition of AMPK 
activator AMP (Figure 4B). We next confirmed by mass spectrometry that Thr28 was the 
site of in vitro AMPK phosphorylation (Figure 4C). In order for AMPK to phosphorylate 
Cytc in kidney the proteins have to physically interact inside the cell. Under basal 
conditions, co-immunopreciptation experiments using extracts from total mouse kidney 
tissue as well as highly purified mitochondria shows interaction of AMPK with Cytc (Figure 
4D). Furthermore, submitochondrial fractionation of highly purified mitochondria indicates 
that AMPK and its activated phosphorylated form is present in the mitochondrial 
intermembrane space (Figure 4E, lane 2), as is Cytc. Finally, activation and inhibition of 
AMPK in mouse kidney tissue using A769662 and Compound C, as confirmed by 
phosphorylation of AMPK target phospho-acetyl-CoA carboxylase (Figure 4F), results in 
increased and decreased threonine phosphorylation of Cytc, respectively (Figure 4G), 
which inversely correlates with intact mitochondrial respiration rates (Figure 4H), mirroring 
data presented in Figures 1 and 2. It is important to note that no such effects were 
observed using liver tissue (data not shown), suggesting tissue-specific differences in the 
regulation of Cytc, which agrees with our previous studies demonstrating that liver Cytc 
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is Tyr48 phosphorylated. 
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Figure 4. AMPK interacts with and phosphorylates cytochrome c on Thr28. 
(A) In vitro AMPK kinase assay with cow heart Cytc, conducted in the absence of AMPK 
activator AMP, shows a time-dependent increase of threonine phosphorylation as 
determined by Western analysis. 
(B) In vitro AMPK kinase assay with cow heart Cytc shows an increase of threonine 
phosphorylation in the presence of AMPK activator AMP. 
(C) Cytc subjected to in vitro AMPK kinase assay as in (A) is phosphorylated on Thr28 as 
determined by the Nano-LC/ESI/MS/MS spectrum of HKpTGPNLHGLFGR. The 
phosphorylation site was unambiguously assigned by fragment ions y10 and y11. The 
sequence of the peptide was assigned by b2, b8, b9, y2, y5, y6, y8, y9, and y10.  
(D) Immunoprecipitation (IP) of AMPK from total mouse kidney extracts and purified 
mitochondrial extracts shows interaction of AMPK with Cytc.  
(E) Submitochondrial fractionation of sucrose gradient purified mouse kidney 
mitochondria shows AMPK and p-AMPK localization to the mitochondrial intermembrane 
space (IMS). Lane 1, mitochondrial lysate; lane 2, intermembrane space; lane 3, pellet 
after outer mitochondrial membrane permeabilization containing outer mitochondrial 
membrane, mitoplasts and residual IMS; lane 4, kidney tissue homogenate. 
(F) Incubation of mouse kidney tissue with AMPK activator A769662 and inhibitor 
Compound C leads to activation and inhibition of AMPK, respectively, as deduced by 
AMPK target phospho-acetyl-CoA carboxylase (p-ACC). 
(G) Pull-down of Cytc from mouse kidney tissue after treatment with AMPK activator 
A769662 and inhibitor Compound C leads to an increase and decrease of Cytc threonine 
phosphorylation, respectively. 
(H) Incubation of mouse kidney tissue with AMPK activator A769662 and inhibitor 
Compound C leads to decreased and increased intact mitochondrial respiration as 
determined in tissue homogenates.  
(I) Model of the regulation of electron transport chain activity through phosphorylation of 
Cytc. Under healthy conditions Cytc is phosphorylated, leading to a partial inhibition of 
mitochondrial respiration. This in turn maintains healthy intermediate membrane 
mitochondrial potentials (m) that are sufficient for effective energy production but 
prevent the generation of ROS, which occurs at pathologically high m values. 
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2.4 Discussion and summary 
                Very little is known about the regulation of mitochondrial oxidative 
phosphorylation by cell signaling. We have previously reported two distinct tyrosine 
phosphorylation sites on Cytc from mammalian heart and liver tissue. The current report 
functionally characterizes a third tissue-specific phosphorylation site, Thr28 mapped on 
Cytc purified from kidney. The same site was also mapped, but not further studied, in a 
high-throughput mass spectrometry study using resting human skeletal muscle 100, 
suggesting that Thr28 can be targeted to regulate ETC function beyond kidney tissue. 
Here, we have isolated Cytc from kidney in which the majority (between 60-80%, 
depending on the preparation) of the protein is phosphorylated at Thr28. In addition, we 
have mutated Thr28 to glutamic acid, a phosphomimetic amino acid, and alanine, a non-
phosphorylatable control mutation, to further characterize the effects of this 
phosphorylation in vitro and in cultured murine lung fibroblast cells lacking both Cytc 
isoforms, the only Cytc double knockout cell line available.  
                Bovine in vivo phosphorylated and unphosphorylated Cytc as well as 
overexpressed mouse WT, Thr28Glu, and Thr28Ala Cytc generated hyperbolic kinetics 
in the reaction with purified bovine liver CcO. All Cytc species exhibited KM values from 4 
to 10 micromolar. Maximal turnover was reduced by 50% and 73% for in vivo 
phosphorylated and phosphomimetic Cytc, respectively. Furthermore, expression of 
phosphomimetic Thr28Glu Cytc led to a reduction of respiration in intact cells suggesting 
for the first time that modification of the small electron carrier can control overall ETC flux. 
These findings are consistent with the concept that phosphorylation of mitochondrial 
proteins, in general, down-regulates whereas dephosphorylation activates mitochondrial 
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function 101. Reduced respiration rates both in vitro with purified CcO and in intact cells 
expressing Thr28Glu Cytc may be a result of the observed change in the redox midpoint 
potential as well as structural changes of the protein. Thr28 lies in the center of an unusual 
structural element termed “negative classical gamma turn,” which is composed of 
residues 27-29 and important for the stability of Cytc 102. Thr28 is a surface residue close 
to the solvent exposed and accessible tip of the heme group that mediates electron 
transfer to CcO. It is located on the frontal right side of the molecule in the conventional 
view (Figure 3A), which is part of the circular, positively charged epitope surrounding the 
heme crevice with which Cytc binds to the corresponding negatively charged epitope on 
CcO 12. Interestingly, in this computational Cytc-CcO docking model, Thr28 is located at 
the interface of catalytic subunits I and II and nuclear encoded subunit VIIc, with closest 
distances of <6Å with Lys47 of subunit VIIc, and of <7Å with Asp50 of subunit I and 
Trp104 and Ser202 of subunit II (Supplemental Figure 4G). Two of the four CcO residues 
are particularly noteworthy. Asp50 is one of only a handful of residues in the entire CcO 
complex that have noticeably different geometries between the reduced and oxidized 
state in the crystal structure 103. In addition, Asp50 is located next to another flexible amino 
acid, Asp51, which, when mutated to Asn, blocks proton pumping of the enzyme and was 
proposed to be the proton ejection site of CcO 104. Phosphorylation of Thr28 may interfere 
with the outward movement of the Asp50-Asp51 region and thus the opening of the 
proposed proton exit channel during reduction of CcO. This would lead to inhibition of 
CcO by inhibiting electron transfer-coupled proton pumping. Alternatively, repulsion 
between phospho-Thr28 and Asp50 may result in suboptimal binding to CcO, causing 
reduced respiration rates. The second interesting interaction site on CcO is Trp104, which 
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is the site of CcO where electrons from Cytc enter CcO before reaching the first metal 
center, the binuclear CuA site. Spatial interference upon Cytc Thr28 phosphorylation with 
Trp104, which is essential for catalysis, could also explain reduced activity. Analogous 
considerations may also be applicable for the interaction of Cytc with bc1 complex. 
                We have previously shown that phosphomimetic Tyr48Glu Cytc is incapable of 
downstream caspase activation 75. In contrast, phosphorylation of Cytc Thr28 or its 
phosphomimetic substitution does not interfere with the ability of Cytc to trigger 
downstream caspase activation. This difference agrees with the observation that the 
Tyr48 epitope is directly involved in the interaction of Cytc with Apaf-1, whereas the Thr28 
epitope is not 105. 
                We observed threonine phosphorylation of Cytc from kidney but not from liver 
tissue, where Cytc is phosphorylated on Tyr48 under basal conditions 74. Signaling 
molecules including AMPK are expressed in a tissue-specific manner, which may in part 
explain tissue-specific differences in cell signaling. Trimeric AMPK consists of three 
subunits, each of which composed of several isoforms. The primary isoforms found in 
kidney are 1, 1 and 2, and 1 and 2 106. Future work should identify which AMPK 
subunit composition is present in kidney mitochondria. Cell signaling also operates 
differently in different organisms. Ser/Thr/Tyr-phosphorylations are most common in 
mammals whereas His/Arg/Lys/Asp-phosphorylations are common in bacteria but not in 
mammals. A recent study compared 285 Cytc sequences across all phyla from humans 
to bacteria 107. Overall, threonine is the most common amino acid at position 28 and 
conserved in mammals. However, in some non-mammalian organisms five other amino 
acids can also be found, namely Gln, Val, Ile, Ser, and even the phosphomimetic Glu, 
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which is present in several plants including potatoes and tomatoes. Interestingly, alanine 
is not among the residues evolutionarily tolerated in this position. We found that Thr28Ala 
Cytc has a higher ability to activate downstream caspases and unfolds more easily, which 
increases CL oxidation. Its instability compared to WT and Thr28Glu Cytc is also 
suggested in the respective circular dichroism spectra (Supplemental Figure 1C, see 
lower wavelength range). In addition, Thr28Ala Cytc is most rapidly oxidized and 
degraded in the presence of H2O2. These features of the Thr28Ala mutant may explain 
why it was evolutionarily selected against. Structural analysis of all three Cytc variants 
shows that the amino acids comprising the negative classical gamma turn element display 
by far the highest root-mean-square deviation values compared to any other Cytc 
sequence, suggesting that the Thr28 epitope is the most flexible element of the entire 
molecule. A plot of the average temperature factors, which for these high resolution 
structures are a reasonable measure of local mobility, also showed that the highest 
relative values, other than at the termini, occurred at the 22-30 loop for all three structures. 
Furthermore, molecular dynamics simulations of crystalized Thr28Ala Cytc produce a 
structure in which the Thr28 C atom is moved by 11.9 Å, over twice as far compared to 
WT, Thr28Glu, and modeled phospho-Thr28 Cytc (Figure 3). These findings collectively 
suggest that alanine was evolutionarily selected against, since it introduces additional 
flexibility, likely due to its small size, at a site near the heme crevice leading to a 
detrimental reduction of protein stability and interference with its multiple functions. This 
may also at least in part account for the finding of lower Cytc protein levels in cells 
expressing this mutant. Another evolutionarily forbidden substitution,Thr28Asp, which 
introduces a negative charge, also generates “rogue” functional changes in Cytc as seen 
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in the reaction with CcO that are even opposite 108 of what we report with in vivo 
phosphorylated Cytc, while glutamate replacement as used here, produces the same 
functional effects as phosphorylated Cytc. These findings collectively suggest that some 
amino acids such as alanine and aspartate were evolutionarily selected against, since 
they alter the functions of Cytc.  Alanine replacement introduces additional flexibility, likely 
due to its small size, at a site near the heme crevice leading to a detrimental reduction of 
protein stability and interference with its multiple functions. This may also at least in part 
account for the finding of lower Cytc protein levels in cells expressing this mutant. 
                Our studies suggest that AMPK targets Cytc for Thr28 phosphorylation within 
the mitochondria. AMPK is one of the most important and evolutionarily oldest metabolic 
sensors and regulators 109. It is implicated in human disease including diabetes, where its 
activity is impaired in several organs including the kidneys 110. Generally, AMPK promotes 
catabolic processes, and it is activated by phosphorylation and allosterically under 
conditions when ATP levels drop and AMP levels increase. However, our understanding 
of the role of AMPK specifically in the kidney is in its infancy 111, and there are reports 
suggesting that it operates differently in this organ compared to other tissues. For 
example, AMPK is already active in kidney under basal conditions and shows a 
paradoxical decrease in activity in a rat kidney ablation and infarction model 112, a 
condition when energy depletion and thus demand is maximal. In cells from patients with 
hereditary leiomyomatosis renal cell cancer, the Krebs cycle is inhibited, which also leads 
to a paradoxical decrease of AMPK activity 113. The high basal activity of AMPK also 
observed in this study (Figure 4F) may be due to the fact that kidneys are always active 
and rely heavily on oxidative phosphorylation 93. Consistent with our findings that AMPK-
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mediated Cytc phosphorylation partially suppresses mitochondrial respiration, it was 
shown in human renal proximal tubular epithelial cells that additional activation of AMPK 
with metformin results in a significant reduction of cellular respiration 114. We propose a 
model, shown in Figure 4I, that a central role of Cytc Thr28 phosphorylation in kidney is 
to maintain optimal intermediate m levels, which allow efficient energy production but 
prevent ROS generation because ROS are produced at high m levels (reviewed in 115. 
In line with our concept, it was shown in rats subjected to renal ischemia/reperfusion injury 
that application of a high dose of AMPK activator AICAR shortly before ischemia 
significantly improves cell survival 116. Cytc purified from ischemic kidney is 
dephosphorylated (not shown) similar to Cytc isolated from ischemic brain 71. This would 
allow maximal ETC flux, m hyperpolarization, and ROS production during reperfusion 
when ETC function is reinstated due to reintroduction of oxygen. We have shown that 
neuroprotective insulin treatment prior to brain ischemia/reperfusion leads to Cytc Tyr97 
phosphorylation, which also decreases respiration, resulting in suppression of the release 
of Cytc from the mitochondria, and a 50% reduction of neuronal death 71. It will be 
interesting to see in future studies if AICAR treatment maintains Cytc Thr28 
phosphorylation during ischemia in kidney, alleviating ETC hyperactivation during 
reperfusion.  
                In conclusion, all three functionally studied Cytc phosphorylations to date, 
Tyr97, Tyr48, and Thr28, lead to a partial inhibition in the reaction with CcO, or ‘controlled 
respiration’ (Figure 4I). We propose that this mechanism provides a basis for the 
maintenance of ‘healthy’ intermediate m levels under normal conditions. This, in turn, 
prevents excessive ROS production that occurs at high m levels under conditions of 
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stress when mitochondrial proteins become dephosphorylated, allowing maximal ETC 
flux, m hyperpolarization, excessive ROS, and cell death. Although all 3 known Cytc 
phosphorylations limit respiration, the choice of site in a particular tissue may depend on 
tissue-specific metabolic differences or on additional effects of the phosphorylation, such 
as the participation of Cytc in apoptosis. 
2.5 Supplemental Figures 
 
Supplemental Figure 1A. Alignment of mammalian somatic (top) and testes (T, bottom) 
Cytc sequences. Conserved amino acids are highlighted in yellow. Thr28 is highlighted 
in bold print. Accession numbers: NP_061820 (human); NP_001157486 (horse); 
NP_001039526 (cow); NP_001123442 (pig); NP_001183974 (dog); CAA25899 (mouse); 
NP_036971 (rat); EPQ18492 (bat); AJF48831 (goat); AFN27378 (dolphin); AAI02715 
(bull testes); AAH59728 (mouse testes); NP_036972 (rat testes). 
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Supplemental Figure 1B. Spectral analysis of overexpressed and purified reduced WT 
(blue), Thr28Ala (green), Thr28Glu (red), and cow heart Sigma Cytc as control (cyan) 
indicates correct folding and functionality of the proteins. 
 
 
Supplemental Figure 1C. Circular dichroism spectra are similar for WT, Thr28Glu, and 
Sigma Cytc (SCC), whereas the Thr28Ala mutant shows spectral differences as lower 
wavelengths. 
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Thr28Glu WT 
SCC 
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Supplemental Figure 2. Unphosphorylated (WT) and in vivo phosphorylated (pT28) Cytc 
have a similar ability to induce caspase 3 activation in a cell free caspase assay. 
 
 
 
 
 
  
C
a
s
p
a
s
e
 a
c
ti
v
a
ti
o
n
 
(%
 o
f 
u
n
p
h
o
s
p
h
o
ry
la
te
d
 C
y
tc
) 
0 
20 
40 
60 
80 
100 
120 
WT Cytc pT28 Cytc 
59 
 
 
60 
 
Supplemental Figure 3.  
(A) Residues and water molecules near Thr28 in the WT protein (green carbon atoms) 
are shown with their electron density contoured at one sigma. To minimize the effects of 
differing side chain lengths and to make this figure for WT comparable to those for T28A 
and T28E, it includes all groups within 4 Å of Glu28 superposed onto Thr28. The heme 
(PDB code Hec) groups have magenta carbon atoms for contrast. The covalent links from 
Cys17 SG to the Hec vinyl groups (see Supplemental Table 1) are shown as black 
dashes. Hydrogen bonds are indicated with gray dashed lines.  
(B) Equivalent to (A) above but for the T28A structure (5C9M.pdb), residues and water 
molecules near Ala28 (green carbon atoms) are shown with their electron density 
contoured at one sigma. To make this figure for T28A comparable to those for WT and 
T28E, it includes all groups within 4 Å of Glu28 superposed onto Ala28. Ile81/A, which is 
shown in Fig. 3xA and 3xC is omitted here because it was 4.1 Å from Glu28 in the 
superposed structure of T28E. 
(C) Equivalent to A above but for the T28E structure (5DF5.pdb), residues and water 
molecules within 4Å of Glu28 (green carbon atoms) are shown with their electron density 
contoured at one sigma. The terminal oxygen atoms of the two Glu28 residues share two 
hydrogen bonds (2.72 & 3.25 Å) and are presumed to be protonated. 
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Supplemental Figure 4.  
(A) Average B-Factors. The average temperature factor (B-factor) for the main chain 
atoms in WT (black), Thr28Ala (red), and Thr28EGlu (blue) are shown plotted by residue 
position. 
(B) The negative (red) and positive (blue) electrostatic potential (ESP) are shown 
contoured at 20 kcal/mole for the WT protein shown as a “tube” tracing. The side chain 
atoms (magenta) of Thr28 are shown as balls. The ESP was calculated by YASARA using 
the recommended Nova force field in vacuo at pH 7.4. The ESP plot for the T28A mutant 
(not shown) is indistinguishable from this figure.  
(C) The negative (red) and positive (blue) electrostatic potential (ESP) are shown 
contoured at 20 kcal/mole for the T28E mutant shown as a “tube” tracing. The side chain 
atoms (magenta) of Glu28 are shown as balls. The ESP was calculated by YASARA using 
the recommended Nova force field in vacuo at pH 7.4. 
(D) The negative (red) and positive (blue) electrostatic potential (ESP) are shown 
contoured at 20 kcal/mole for the phosphor-Thr model (Tpo28) shown as a “tube” tracing. 
The side chain atoms (magenta) of Tpo28 are shown as balls. The ESP was calculated 
by YASARA using the recommended Nova force field in vacuo at pH 7.4. 
G 
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(E) The entire WT “tetramer” in the unit cell of space group P1 is shown with its six 
hexacyanoferrate(3-) ligands (PDB code FC6) identified with “X” as a one letter code in 
this figure. X202a&b/A and X203a&b/B are pairs of FC6 ligands with partial occupancies 
and alternate positions (Supplemental Table 1) that physically overlap with each other 
and cannot be occupied simultaneously. The ESP was calculated by YASARA using the 
recommended Nova force field in vacuo at pH 7.4. The T28A tetramer, which is not 
shown, was crystallized under the same conditions as the WT protein, and has very 
similar FC6 ligands (Supplemental Table 1) and the same ESP contours. 
(F) The entire T28E “tetramer” in the unit cell of space group P1 is shown with its three 
hexacyanoferrate(3-) ligands (PDB code FC6) identified with “X” as a one letter code. The 
ESP was calculated by YASARA using the recommended Nova force field in vacuo at pH 
4.5. Given the close proximity and presumed hydrogen bonding between pairs of Glu28 
residues (Supplemental Figure 3C) their pKa values were manually set to 7.0 so they 
would be protonated during the calculation of the ESP. 
(G) Docking model of Cytc and CcO 12. Residues on CcO within a distance of 7 Å from 
Thr28 (red) are highlighted (Lys47 of CcO subunit 7c, magenta; Asp50 of CcO subunit I, 
yellow; Trp 104, green, and Ser 202, cyan, of CcO subunit II). 
 
Supplemental Table 1. Crystallographic Data1 
STRUCTURE 
CYTC (WT) 
MOUSE 
CYTC (T28A) 
MOUSE 
CYTC (T28E) 
MOUSE 
CYTC (Y47F) 
HUMAN2 
PDB CODE 5C0Z 5C9M 5DF5 3ZOO 
CRYSTALLIZAT
ION 
  
 
 
Iron Oxidized Oxidized Oxidized Oxidized 
Protein 
15 mg/mL Cytc 
(WT) + 5 mM 
22 mg/mL Cytc 
(T28A) + 5 mM 
15 mg/mL Cytc 
(T28E) + 5 mM 
12.5 mg/mL 
oxidized protein 
in 22.5% (w/v) 
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K3Fe(CN)6 in 
water 
K3Fe(CN)6 in 
water 
K3Fe(CN)6 in 
water 
PEG 1000, 50 
mM KH2PO4, pH 
7.0 
Well 
25% PEG 4K, 
8% isopropanol, 
0.1 M Na 
acetate, pH 6.5 
25% PEG 4K, 
8% isopropanol, 
0.1 M Na 
acetate, pH 6.5 
30% PEG 1500, 
pH 4.5 
26-31% (W/V) 
PEG 1000, 40 
mM, KH2PO4 pH 
7.0 
Drop 1:1 protein:well 1:1 protein:well 1:1 protein:well n/a 
Cryoprotectant 
30% PEG 4K, 
8% iso propanol, 
0.1M Na acetate, 
20% ethylene 
glycol, 10 min 
soak with 5 mM 
K3Fe(CN)6  
30% PEG 4K, 
8% iso propanol, 
0.1 M Na 
acetate, 20% 
ethylene glycol, 
10 min soak with 
5 mM K3Fe(CN)6  
35% PEG 1500, 
20% ethylene 
glycol 
26-31% (w/v) 
PEG 1000, 40 
mM, KH2PO4 pH 
7.0, 15% 
glycerol   
CRYSTAL DATA     
Space group: P1 P1 P1 P1 
Unit cell: a 34.401 34.517 34.609 36.367 
b 52.471 52.567 51.739 53.952 
c 61.647 61.771 61.748 58.95 
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Alpha 110.04 109.86 110.01 76.55 
Beta 92.77 92.93 93.09 88.73 
Gamma 92.02 92.20 91.88 71.86 
Chains per A.U. 4 4 4 4 
Matthews 
Coeff. 
2.24 2.27 2.25 2.3 
Solvent % 45.12 45.7 45.26 46.7 
X-RAY DATA      
Resolution-
high (Å) 
1.124 1.36 1.30 1.35 
Resolution-low 
(Å) 
49.22 57.96 57.88 30.59 
Beamline  APS 21-ID-F  APS 21-ID-F  APS 21-ID-D 
DIAMOND 103 
(UK) 
Wavelength 0.97872 0.97872 1.07812 0.9762 
Reflections 127840 76544 90455 81707 
Completeness 87.4 (44.66) 92.4 (66.2) 96.6 (89.38) 94.73 (80.71) 
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Average 
I/sigma 
14.4 (2.0) 14.1 (2.2) 14.9 (2.4) 8.70 (n/a) 
Redundancy 3.9 (3.7) 3.9 (3.8) 5.3 (4.2) n/a 
Rmerge 0.05 0.052 (0.580) 0.081 (0.504) 0.07 
REFINEMENT     
Rfactor  0.132 (0.239) 0.129 (0.229) 0.148 (0.256) 0.13821 
Rfree 0.159 (0.240) 0.170 (0.303) 0.178 (0.252) 0.17935 
Avg. B-factor 
(Å2) 
15.97 21.41 19.32 17.703 
Protein atoms 
per A.U. 
3228 3220 3236 3981 
Water 
molecules 
537 472 334 417 
Bond RMSD 0.017 0.016 0.018 0.017 
Angle RMSD 1.903 1.803 1.884 1.99 
Chiral RMSD 0.124 0.122 0.131 0.125 
FC6 
OCCUPANCY 
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202a/A 0.28 0.35 –  
202b/A 0.37 0.34 –  
202/B 0.93 0.98 0.92  
203/B – – 0.48  
203a/B 0.30 0.39 –  
203b/B 0.32 0.28 –  
202/C 0.90 1.00 0.89  
HEME LINKS:     
C14 SG - HEM 
CAB (Å) 
    
Chain-A 1.86 1.92 1.91 1.93 
Chain-B 1.86 1.93 1.90 1.96 
Chain-C 1.91 1.94 1.95 1.96 
Chain-D 1.95 2.02 1.94 1.93 
Average 1.90 1.95 1.93 1.95 
C17 SG - HEM 
CAC (Å) 
    
Chain-A 1.98 2.09 1.96 2.06 
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Chain-B 1.94 2.07 1.99 2.21 
Chain-C 1.97 2.12 2.07 2.16 
Chain-D 2.04 2.21 2.06 2.08 
Average 1.98 2.12 2.02 2.13 
H18 NE2 - FE2 
(Å) 
    
Chain-A 2.02 2.03 2.00 2.00 
Chain-B 2.03 2.00 2.02 2.06 
Chain-C 2.02 2.04 2.03 2.01 
Chain-D 2.01 2.07 2.02 2.02 
Average 2.02 2.04 2.02 2.02 
M80 SD - FE2 
(Å) 
    
Chain-A 2.29 2.27 2.28 2.29 
Chain-B 2.28 2.27 2.27 2.29 
Chain-C 2.30 2.28 2.30 2.24 
Chain-D 2.31 2.27 2.29 2.29 
Average 2.30 2.27 2.29 2.28 
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                    1All three structures have 4 molecules in a P1 unit cell with very similar 
dimensions. When the twelve independently refined Cytc molecules are overlapped with 
each other using their main chain atoms, the average RMSD value among the 66 unique 
pairs is 0.189 Å, and the highest value is 0.280 Å between chain-A in WT and chain-D in 
Thr28Glu. Comparing equivalent chains, the three A-chains have the smallest RMSD 
(0.080 Å) followed by the B-chains (0.107 Å), the D-chains (0.0.113 Å) and the C-chains 
(0.140 Å). The three Cytc “tetramers” reported here have a similar orientation in the P1 
unit cell. The Thr28Ala and Thr28Glu mutants have RMSD values, based on backbone 
atoms, of 0.151 Å and 0.330 Å, respectively, when superposed on the WT structure as 
tetramers. The Thr28Ala structure is more similar to the WT structure because it was 
crystallized at pH 6.5 from the exact same conditions as the WT protein, whereas the 
Thr28Glu mutant was crystallized from a different solution at pH 4.5.  The Thr28Glu 
mutant only crystallized at pH 4.5 because the four Glu28 residues, are arranged in 
closely adjacent pairs in the “native” tetramer and destabilizes the crystal packing if they 
are deprotonated (see Supplemental Figures 3 and 4). The Thr28Glu crystal structure 
has the same two major FC6 ligands (FC6 202/B and FC6/C), as the WT structure and a 
third, unique site (FC6 203/B), which is possibly related to the lower pH. It has no 
significant density for the two minor sites (FC6 202/A and FC6 203/B) in the WT and 
Thr28Ala crystal structures. The lower occupancies of the minor FC6 sites suggest they 
are weakly bound and were probably lost from the Thr28Glu crystals during the crystal 
freezing procedure, which used a cryo-solution soak that did not include the FC6 reagent. 
                    2Mouse and human Cytc monomers are similar but their tetramers differ: The 
mouse WT structure was solved using chain-A from the crystal structure of human Cytc 
(see Methods), and the two refined chains have a RMSD of 0.266.  Also, the three mouse 
structures, like the human structure, were solved and refined using the free heme moiety 
(PDB ligand code: HEM) and finished with very similar, unconstrained bond distances for 
the dative bonds to heme iron and the covalent links to Cys14 and Cys17. In contrast, the 
tetramers observed in both crystal structures, have a RMSD overlap of 17 Å because the 
Cytc molecules have very different orientations within the tetramer (not shown). The 
tetramers are crystal entities and do not exist in solution. All three Cytc monomers – WT, 
Thr28Ala, Thr28Glu – have a region with strong positive electrostatic potential (ESP) 
(Supplemental Figure 4E and F). In the three structures reported here, the monomers are 
arranged with their positive ESP regions adjacent to each other in pairs. This arrangement 
is possible because the FC6 ligands with their -3 charge balance the strong positive ESP. 
The human Cytc lacks these ligands. Consequently, the monomers are rotated within the 
human tetramer so the ESP potentials are distant from each other (not shown). 
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CHAPTER 3 SUMMARY 
                To understand how Cytc phosphorylation is induced under stressed conditions, 
and how it functions in protecting tissues affected by that stress, we performed a second 
study where the phosphorylation status of Cytc in ischemic brain was investigated. The 
following article demonstrates how insulin-induced neuroprotection and inhibition of Cytc 
release under conditions of brain ischemia was connected to Cytc phosphorylation. Our 
data suggest that phosphorylation of Cytc occurs in an insulin-dependent manner, and 
significantly reduces induction of apoptosis via prevention of Cytc release from 
mitochondria (manuscript published in PLoS One, 2013 8(11):e78627). 
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CHAPTER 4 CONCLUSIONS AND FUTURE DIRECTIONS 
                This dissertation set out to investigate the role Cytc phosphorylation plays in 
various aspects of life, under physiologically healthy and stressed conditions, and to use 
biochemical and molecular biological techniques to decipher the mechanisms affected by 
it. In this final chapter, I will review the research contributions of this dissertation, as well 
as discuss directions for future research. 
4.1 Conclusions 
                The importance of cell signaling pathways in regulating protein functions have 
been known for many years. Mitochondrial proteins have been known to be post-
translationally modified, altering their functions under influence from cell-signaling 
pathways targeting them. The understanding of how phosphorylation of mitochondrial 
electron transport chain (ETC) protein Cytc function is naturally of great importance and 
was the main motivation for this thesis. The work consisted of three parts: discovering the 
amino acid residue that are endogenously phosphorylated on Cytc under physiologically 
healthy conditions in tissues like kidneys and brain, the effect of these phosphorylations 
on the functioning of the protein, for example control of the rate of reduction, and the 
transfer of electrons between complexes III and IV of the ETC, and discovering the 
kinase(s) that are responsible for the phosphorylations on the protein. As models for our 
study, the following proteins were used: the wild-type rat Cytc protein, the 
phosphomimetic Thr28Glu Cytc mutant, and the non-phosphorylatable Thr28Ala Cytc (an 
additional control). This thesis research has contributed incremental but significant results 
for the continuing study of phosphorylated mitochondrial proteins, and some suggestions 
for further work. Multiple studies from our laboratory showed that Cytc is tightly regulated 
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by post-translational modifications, especially phosphorylation. Site-specific 
phosphorylations on Cytc were discovered in our laboratory with the help of techniques 
of purification of the protein that helps in preserving the physiological phosphorylation 
status of the protein, as it was present within the healthy live tissue. Cytc was previously 
isolated from mammalian heart and liver tissues in our laboratory and site specific tyrosine 
phosphorylations were detected by Nano/LC/ESI/MS/MS. Experiments showed that 
these phosphorylations had significant impact on the various functions of the protein, 
proving that phosphorylation of the protein is undoubtedly important. These results led to 
our overall hypothesis that Cytc phosphorylation does regulate the two major functions of 
Cytc, mitochondrial respiration and Cytc release during apoptosis. The long term goal of 
our laboratory is therefore to understand the effect of Cytc phosphorylation on respiration 
and apoptosis, and to identify the cell signaling pathways directed to Cytc.   
                This thesis research aimed at understanding Cytc phosphorylation in detail, by 
investigating the project via addressing three specific aims: 1) testing the hypotheses that 
Cytc is in vivo phosphorylated under physiologically healthy conditions in a distinct tissue-
specific manner, 2) testing the hypotheses that phosphorylation of Cytc leads to controlled 
respiration and prevents its participation in activation of the Cytc-mediated apoptosis 
cascade, and 3) to systematically identify mitochondrial kinases that phosphorylate Cytc 
on specific residues in a tissue-specific manner. Whether these phosphorylations result 
in structural changes of the protein is under study. This thesis research discloses that the 
long recognized central molecule in respiration and apoptosis, Cytc, is regulated by cell 
signaling pathways that target mitochondria under healthy conditions, opening new 
avenues to understand and control the two main biological processes that depend totally 
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on this small single electron carrier protein.  In a follow-up study, we are analyzing 
whether there are any structural changes brought about by site-specific phosphorylation, 
and identify the kinases and phosphatases that phosphorylate and dephosphorylate Cytc. 
Since Cytc-mediated apoptosis and cellular respiration play a crucial role in many 
diseases such as cancer and neurodegeneration, this study is anticipated to provide 
better understanding and control of such diseases.  
                Cell signaling pathways that target the mitochondria are not well defined and 
are poorly understood. Major metabolic regulators that are known to affect mitochondrial 
functions, such as insulin, glucagon, and calcium, have not been well studied to reveal 
their mechanism of action. However, our laboratory has published protocols to isolate 
mitochondria and ETC components which preserve their endogenous phosphorylation 
state, and we provide compelling evidence that cell signaling pathways act on Cytc in a 
distinct and tissue-specific manner. During this thesis research, we developed methods 
to assess the levels of endogenous Cytc phosphorylation, and for the first time, we 
identified the kinase that phosphorylates Cytc in kidney tissues under healthy conditions, 
phosphorylating Cytc at Thr28 residue. We show that it is the AMP-kinase-mediated 
phosphorylated form of Cytc that exists in healthy kidney tissues in vivo, and functional 
studies revealed that phosphorylation on this site leads to controlled respiration, reduced 
cardiolipin peroxidase activity, which is required for its release from the mitochondria 
during apoptosis, and unaltered capability to induce caspase activation with Thr28 
phosphomimetic Cytc. This research indicates that Thr28 site is important in the redox-
functioning of the protein, and plays an important role in maintain the native structure and 
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functions of the protein under healthy conditions, when the protein resides within the 
mitochondrial intermembrane space. 
4.2 Future directions 
                To further advance our understanding of how phosphorylation of Cytc affected 
its functions under physiological conditions, several steps can be taken to address 
questions that arise with this research. 
4.2.1 How to better study tissue-specific phosphorylations? 
                Tissue-specific phosphorylations can be better studied by approaching to study 
tissue-specific phosphorylations by creating animal models expressing phosphomimetic 
Cytc in individual sites in tissues that they were discovered in, and comparing them with 
wild type Cytc expressing animals. This will address multiple questions at the same time. 
We will be able to find out how the phosphorylation of the protein alters the animal’s ability 
to survive conditions which are stressful under physiological conditions. 
                Second, to discover the level and sites that are physiologically phosphorylated 
in different tissues within one healthy animal, purification of Cytc can be performed 
followed by mass spectrometry. This would give an overall understanding of the 
phosphorylations that exist in a healthy animal at a time, in different tissues. Then, 
changes in the phosphorylation profiles in different tissues could be studied under 
different stressed conditions. Also, changes in the protein functions can also be measured 
by various assays that has been performed in this thesis project. Changes in cellular 
activities could also be monitored by isolation of primary cells and/or intact mitochondria 
from various tissues under different conditions. This would signify how Cytc 
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phosphorylation maintains healthy conditions of tissues and how it is affected by stress, 
thereby affecting the protein’s functions. 
                Third, if more than one site is phosphorylated in the protein purified from the 
same tissue, then double as well as single phospho-mimetic mutant proteins can be 
prepared, and the activities can be compared to one another, as well as the wild type 
protein. This will suggest if phosphorylation on one particular site lead to altered activities 
or if it is a combination of all the existing phosphorylations.  
                Fourth, deciphering the different kinases and phosphatases within the 
mitochondrial intermembrane space targeting the Cytc protein and phosphorylating it on 
different sites will suggest the combination of signaling pathways that converge on 
mitochondria of a specific tissue at a time, and result in Cytc phosphorylation. 
Experiments performed to find out if any one site affected the protein’s function more than 
the other will indicate which signaling pathway has a stronger impact on mitochondrial 
functions through Cytc phosphorylation. 
                Fifth, to follow changes in phosphorylation status of Cytc under various stressful 
conditions, antibodies can be raised against Cytc phosphorylated at a particular site. 
These phospho-site-specific antibodies can be used to track changes in the levels of 
phosphorylation on the particular site within tissue-sections or purified proteins. 
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ABSTRACT 
REGULATION OF CYTOCHROME c FUNCTIONS BY PHOSPHORYLATION 
by 
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Major:         Biochemistry and Molecular Biology  
Degree:      Doctor of Philosophy 
                Mammalian cytochrome c (Cytc), the only water-soluble component of the 
electron transfer chain plays a key role in cellular life and death decisions, functioning as 
an electron carrier in the electron transport chain (ETC) and as a trigger of apoptosis 
when released. However, its regulation is not well understood. Modified Cytc purification 
techniques that leads to the purification of the protein maintaining the physiological 
phosphorylation status within the particular organ depicts a novel means of regulation via 
cell signaling pathways that is yet to be studied in detail. Four phosphorylation sites have 
been mapped on mammalian Cytc till date, and two of them have been studied 
functionally, demonstrating that both respiration and apoptosis are under the control of 
signaling pathways that have yet to be identified. Our previous studies showed that Cytc 
is phosphorylated on Tyr48 in liver, on Tyr97 in heart, and here we show that Cytc is 
phosphorylated on Thr28 in kidneys. Our study shows that phosphorylation of Cytc on 
Thr28 causes an inhibition of respiration in the reaction with cytochrome c oxidase. Thr28 
is located at a central position near the heme crevice as we show here by high resolution 
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crystallography. Introduction of Thr28Glu phosphomimetic Cytc into Cytc knockout cells 
shows that intact cell respiration, mitochondrial membrane potential (m), and ROS 
levels are reduced compared to wild-type. Finally, Thr28 phosphorylation is mediated by 
AMP kinase, which colocalizes with Cytc to the intermembrane space. We conclude that 
Cytc phosphorylation leads to regulation of ETC flux via ‘controlled respiration,’ 
preventing m hyperpolarization, a known cause of ROS and a trigger of apoptosis.  
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